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 Abstract 
Tranexamic acid is a non UV/visible absorbing compound. Thus, a suitable 
chromogen is needed to react with it forming absorbing chromophore that 
can be used for simple and sensitive determination of tranexamic acid.   
Objectives                                                                                                  
Development, optimization and validation of two feasible spectro 
photometric methods for quantitive measurement of tranexamic acid.   
Methods                                                                                                                
The spectrophotometric methods are based on the coupling of tranexamix 
acid with 2,6-dichloro quinine-4-chlorimide (DCQ) or ascorbic acid (AA) as 
chromogens forming suitable colored chromophores. 
Results                                                                                                                  
The first method (TA with DCQ) produced a brownish-green colored 
complex with analytically useful wavelength at 670nm and non-stable rather 
flat wavelength around 412nm. The second method (TA with AA) formed a 
purple-pink colored complex with two maximum wavelengths at 530 & 
390nm. Various experimental parameters affecting the color development 
and stability were investigated and incorporated into the procedures.     
Beer’s law was found to be valid over the concentration range 50-250µg/ml 
for TA-DCQ method and 10-25µg/ml for TA-AA method. Regression 
analysis of standard curve plot showed good correlation (R=0.996) for TA-
DCQ method with detection limit 24.01µg/ml and molar absorbtivity 
518.42mol-1 cm-1. Regarding TA-AA method, the correlation coefficient of 
standard curve plot at 390nm was 0.997 with detection limit 1.83µg/ml and 
molar absorbtivity 2.382×103 mol-1 cm-1. At 530nm, the correlation 
coefficient was 0.9989, the detection limit was1.09µg/ml and the molar 
absorbtivity was 0.733×103   mol-1 cm-1. 
Conclusion                                                                                                                    
The two proposed methods are simple, accurate, precise and sensitive. 
Therefore, they are suitable for the determination of tranexamic acid in bulk 
and commercial dosage forms. 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
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1. INTRODUCTION 
1.1. Overview                                                                                                               
It is essential that blood remains fluid within the circulation but clots at sites 
of vascular injury. In normal circumstances there is equilibrium between the 
natural coagulant-anticoagulant & fibrinolytic-antifibrinolytic systems[1].                         
Coagulation process involves platelet activation and aggregation, followed 
by thrombin formation that is stimulated by factors released from the injured 
tissue and platelets.In turn, thrombin catalyzes the conversion of soluble 
fibrinogen into insoluble fibrin monomers, which spontaneously polymerize 
to form the fibrin mesh that stabilizes the clot[1]. 
Bleeding problems may have their origin in naturally occurring pathologic 
conditions such as hemophilia, vitamin K deficiency or as a result of 
fibrinolytic states that may arise after gastrointestinal surgery or 
prostatectomy. The use of anticoagulants may also give rise to 
hemorrhaging[2]. 
Fibrinolysis provides important mechanism to limit propagation of 
intravascular thrombosis. Numerous studies have tried to intervene at this 
level with drugs acting by blocking the fibrinolytic pathway with the aims of 
limiting blood loss during medical or surgical conditions. 
 
Two classes of antifibrinolytic drugs are available for clinical use. These are 
synthetic lysine analogues, epsilon-amino caproic acid (EACA) and 
tranexamic acid (TA), and the natural serine protease inhibitor, aprotinin[3] 
(Figure1-1). Compared with aprotinin, lysine analogues are almost as 
effective, are cheaper and do not appear to increase mortality[4]. The limited 
comparative evidence would suggest that the three drugs are equivalent in 
efficacy and there is little or no advantage to combination therapy[5].  
OH
H 2N
O
NH 2
OH
H 2N
O
O OH
H 2N
 
                                                  Lysine              ߝ-Amino caproic acid    Tranexamic acid  
          Figure (1-1): Molecular structures of the amino acid lysine and its analogues. 
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 1.2. Tranexamic acid                                                                                
 
1.2.1. Definition   
Tranexamic acid is a synthetic lysine analogue anti fibrinolytic drug used to 
prevent bleeding or to treat bleeding associated with excessive fibrinolysis. 
The IUPAC name is trans-4-(aminomethyl) cyclo hexane carboxylic acid. It 
has the molecular formula (C8H15NO2)[6]. 
COOH
NH2  
1.2.2. Physical properties                                                                            
Tranexamic acid (molecular weight: 157.2) is a white crystalline powder. It 
is freely soluble in water and in glacial acetic acid and is very slightly 
soluble in ethanol and practically insoluble in acetone and in alcohol[7]. 
1.2.3.Pharmacological actions  
Plasminogen activators diffuse into thrombus from circulating blood and 
cleave plasminogen to release plasmin. Plasmin acts on the fibrin mesh work 
generating fibrin degradation products and lysing the clot[8].Tranexamic acid 
competitively inhibits the binding of plasmin to fibrin at lysine binding site; 
fibrinolysis is thus retarded[1]. 
In Menstrual bleeding tranexamic acid is used as first line non hormonal 
treatment of dysfunctional uterine bleeding. Tranexamic acid is used in 
orthopedic and cardiac surgery in reducing pre- and postoperative blood loss. 
In dentistry tranexamic acid is used after extractions or surgery in patients 
with prolonged bleeding time, e.g. from acquired or inherited disorders[6]. 
1.2.4. Available dosage forms[7].     
-Solution for injection (100mg/ml).                                                                       
-Tablet (500mg, 650mg).                                                                                                      
-Capsule (250mg, 500mg).  
Tranexamic acid 
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 1.3.Examples of methods used for quantitive analysis of tranexamic acid 
The official method used for assay of tranexamic acid as raw material and as 
tablet present in British pharmacopeia (2002) involves dissolution of the 
drug in anhydrous acetic acid then titration with perchloric acid and 
determination of the end point potentiometrically.   
Assay of tranexamic acid injection (BP 2002) involves neutralization of the 
aqueous drug solution by sodium hydroxide or hydrochloric acid, addition of 
previously neutralized formaldehyde solution and excess sodium hydroxide 
then back titration with hydrochloric acid and determination of the end point 
potentiometrically.    
In addition to these official methods, there are some other reported methods 
used for the assay of tranexamic acid in bulk and in pharmaceutical 
formulations or biological fluids reviewed from the literature.     
-A simple, rapid and precise method is developed for the assay of 
tranexamic acid in pharmaceutical dosage forms. The method was developed 
with HPLC, ELS detector and Alltimacyano 100A (250 x 4.6 mm, 5µ ) 
column, the mobile phase composed of aqueous solution of 0.05% (v/v) tri     
fluoro acetic acid and acetonitrile (60:40 v/v, pH 2.85). The instrumental 
settings are flow rate of 0.5mL min-1, column temperature at 30oC and 
detector drift tube temperature set at 97oC, a detector nitrogen gas flow set at 
2.6 SLPM, gain 1 and 5µ L sample injection volume. Theoretical plates 
were20007. Tailing factor was 1.38. The described method shows excellent 
linearity over a range of 50 to150% of assay concentration. The correlation 
coefficient was 0.9987. The relative standard deviation of six measurements 
for peak area and retention time were less than 2% and 0.5% respectively. 
The proposed method was found to be suitable and accurate for assay 
determination of tranexamic acid in pharmaceutical preparations[9].                                 
-An improved derivatized RP- HPLC method with PDA detection has been 
developed and validated for the simultaneous estimation of tranexamic acid 
(TA) and mefenamic acid (MA) in combined tablet dosage form. The 
method employs precolumn derivatization using 0.2% methanolic ninhydrin 
at primary amino group of TA to form ruhemann purple product. MA could 
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 not react with ninhydrin. The chromatographic estimation was achieved 
using phenomenex C-18 (250 X 4.6 mm, 5µ m) analytical column and the 
mobile phase consisting of methanol and 20mmol-1 acetate buffer (75:25, 
v/v) pH adjusted to 4.0 using orthophosphoric acid at a flow rate of 1.0 
mLmin-1. The UV detection was carried out at 370 nm using photodiode 
array detector. The retention time of TA and MA were found to be 3.9 and 
12.4 min. TA and MA calibration curves were linear with correlation 
coefficient of 0.9973 and 0.9985 at a concentration ranging from 5µ gmL-1 
to25 µ gmL-1. Recovery was between 98.5%- 100.5% for TA and 99.7%- 
104.3% for MA. Limit of detection and quantification were 54.0µgmL-1 and 
62.6µgmL-1 for TA, 12.3ɊgmL-1 and 37.1µgmL-1 for MA. The developed 
method is very sensitive as both peaks were well separated from its 
derivatizing agent peak with a short analysis time of 15 minutes[10].                                                                      
-An effective method for measurement of tranexamic acid in human serum 
has been developed using liquid chromatography coupled to ion-trap mass 
spectrometry (LC-MS/MS). Serum samples (100µL) were subjected to 
protein precipitation with perchloric acid, and after pH adjustment, 
tranexamic acid and internal standard were separated on a C18 column and 
isocratically eluted using a mobile phase constituted of formate 
buffer/acetonitrile (95:5, v/v). Tranexamic acid was ionized by electrospray 
in positive mode. Parent [M+H]+ ions were m/z 158.0 for tranexamic acid 
and m/z 144.0 for IS. The most intense product ion of tranexamic acid (m/z 
122.7) and IS (m/z 126.0) were used for quantification. The assay was 
accurate and precise over the range of 1.0 (lower limit of quantification) to 
200.0µg/ml (upper limit of quantification), and has been successfully 
applied to study the clinical pharmacokinetics in two volunteers undergoing 
cardiac surgery[11].                       
-A simple and rapid densitometric method has been developed for 
determination of tranexamic acid in tablets and its dissolution media. After 
extracting the samples with a mixture of a 96% ethanol and water (1 : 1, 
v/v), the solutions were spotted on precoated silica gel TLC plates, which 
were eluted with a mixture of n- butanol–glacial acetic acid–water 
(8.0 : 2.0 : 2.0, v/v). Quantitative evaluation was performed by measuring 
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 the absorbance reflectance of the tranexamic acid spots at ?  equal to 488 nm 
by using ninhydrin reagent. The TLC- densitometric method is selective, 
precise, and accurate, and can be used for routine analysis of tablets in the 
pharmaceutical industry quality control laboratories[12].     
-A new spectrofluorimetric   method for determination of tranexamic acid in 
hydrogel patch formulations has been developed. derivatization with 
naphthalene-2,3-dicarboxaldehyde(NDA) in the presence of  cyanide ion 
(CN-) to produce a fluorescent 1–cyanobenz isoindole (CBI) product (? ex  = 
420 nm, ? em = 480 nm) is for the first time reported for the determination of 
tranexamic acid in hydrogel patch formulations. Other separation techniques 
were not used in the analysis of the CBI-fluorescent product as required in 
the previous studies. The developed method was proven to be precise and 
accurate with percent recoveries ranging between   98.0% and 101.8% at the 
concentration range of 8.4- 84.0 ߤg/ml (R2 > 0.999). The intra- and inter-day 
precisions as expressed by the relative standard deviations (RSD) were 
below 1.85%. Derivatization of tranexamic acid with NDA/CN was 
completed within five minutes and was stable for at least 30 minutes. The 
method has been applied to the  analysis of drug content and release profiles 
in tranexamic hydrogel patch formulations[13].                                                                                          
 
-Two simple and sensitive spectrophotometric and fluorimetric methods for 
the determination of tranexamic acid in tablets are developed. The methods 
are based on condensation of the primary amino group of tranexamic acid 
with acetyl acetone and formaldehyde producing a yellow colored product, 
which is measured spectrophotometrically at 335nm or fluorimetrically at 
480nm the color was stable for at least 1 hour. Beer's law was valid within a 
concentration rang of 0.05-2.0µ g ml- 1 spectrophotometrically and 0.05-0.25 
µ gml- 1fluorimetrically. All the variables were studied to optimize the 
reaction conditions. No interference was observed in the presence of 
common pharmaceutical excipints. The validity of both methods was tested 
by analyzing tranexamic acid in its pharmaceutical preparations. Good 
recoveries were obtained and the results were comparable with those 
obtained by standard method[14].                                                                                
 
-A simple, rapid, accurate, precise, specific and economical spectrophoto 
metric method for simultaneous estimation of ethamsylate and tranexamic 
acid in combined tablet dosage form has been developed. The developed 
method employs derivatization procedure for making tranexamic acid UV 
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 detectable. It employs formation and solving of simultaneous equation using 
two wavelengths 299.0 nm and 286.2 nm. This method obeys Beer’s law in 
the employed concentration ranges of 4-15µ g mL-1and 2-12µ g mL-1for 
ethamsylate and tranexamic acid respectively. Results of analysis were 
validated statistically and by recovery studies[15]. 
 
-Tranexamic acid was determined spectrophotometrically after derivatizing 
with salicylaldehyde (SA) or 5, 5’-methylene-bis-salicylaldehyde (BSA) at 
neutral pH in aqueous-methanolic solution. The reaction conditions were 
optimized and the derivatives absorbed maximally at 410nm and 412nm for 
SA and BSA respectively. The Beer’s law was obeyed in the range 7.8-18.6 
mg/ml, with coefficient of determination 0.9995 and 0.9998. The methods 
were applied for the determination of tranexamic acid in pharmaceutical 
preparations with coefficient variation 0.76-0.97%[16].                                                                                                          
 
-A simple determination is based on the reaction (at 70°) between 
tranexamic acid and 1-fluoro-2,4-dinitrobenzene in the presence of excess of 
NaHCO3, and measurement of the absorbance at 350nm of the trans-4-(2,4-
dinitro phenyl amino methyl) cyclo hexane carboxylic acid produced. Beer's 
law is obeyed from 1to 15µg ml-1 and Sandell sensitivity is 8.7µgcm-2. The 
method has greater precision and speed than the titrimetric method. 
Excipients do not interfere[17].                                                                               
 
-A new spectrophotometric method has been developed for the assay of the 
tranexamic acid (TA) by derivatization with vanillin (VAN). The molar 
absorptivity of TA was calculated as 25.160Lmol-1cm-1 at ? max 354 nm and 
obeyed the Beer's law within 0.5-2.5µg mL-1. The color reaction was highly 
stable and did not show any change in absorbance up to 24hours.The method 
was applied for the analysis of TA from capsules, injections and tooth 
pastes. The amounts of TA found in capsules, injections and tooth pastes of 
various pharmaceutical companies were observed with 249.0-250.9 
mg/capsule, 249.3-250.7 mg/injection and 0.048%-0.049% in tooth pastes 
with relative standard deviation (RSD) 0.2%-5.0% (n=3)[18] .                                                                                          
 
-Tranexamic acid is reacted with aqueous alcoholic chloranil, buffered at pH 
9, to give a complex with maximum absorption at 346 nm and with an 
apparent molar absorptivity of 15.7x103l.mole-1cm-1. The maximum 
absorbance is linearly related to concentration over the range 2-10 µg ml. 
When applied to tablets labeled as containing 500mg each, the mean found 
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 was 496 ± 4 mg. The results were comparable with those of the tradition
formal titration method for amino 
 
- Two simple, fast, accurate, and sensitive spectro
been developed for the determination of tranexamic acid in 
dosage forms. These methods (A and B) are based on the reaction of 
tranexamic acid as n
dicyano- 1,4- benzoquinone 
(TCNQ) as p - acceptors to give highly colored com
maximally at 470 and 
concentration limit of 
detection (LOD) and limit of quantification (LOQ) were 
found to be 0.18µg/ml and 
0.39µg/ml for method B, respectively. A Job's plot of the absorbance versus 
the molar ratio of tranexamic acid to each of the acceptors under 
consideration indicated 
accurate, precise, and sensitive for the determination of tranexamic acid in 
commercial dosage forms without interferences from common additives 
encountered[20].                                                                                
 
-A spectrophotometric method is described for the determination of some 
drugs containing a primary amino
tranyl cypromine sulfate and tranexamic acid in their pure forms as well as 
in some pharmaceutical dosage forms. The 
formation of a charge
(TCNE) as p -acceptor and the studied drugs as n
presence of acetonitrile as solvent. The spectra of the comple
maxima at 330nm with high apparen
2.2 × 104 Lmol–1cm–1). Beer
25–75µgmL–1, 2–30µgml
recoveries are 99.68±0.92
hydrochloride, tranyl cypromine sulfate and tranexamic acid, respectively. 
The proposed method is simple and can be applied to determine these drugs 
in their pharmaceutical dosage forms. The results compare favorably with 
those of reported methods
                                                                                                                            
-A simple, rapid, precise, highly specific and economical spectro
metric method has been developed fo
in its pharmaceutical dosage forms. The method is based on the re
acids[19].                                                                      
photometric methods have 
- electron donor  with 2,3- dichloro
(DDQ)  and 7,7,8,8- tetracyanoquinodimethane 
plex species that absorb 
750 nm, respectively. Beer's law was obeyed in the 
0.5-10 µg/ml for tranexamic acid. The limit of 
0.60µg/ml for method A and 
1:1. The proposed methods were foun
-group, i.e. amantadine hydrochloride, 
procedure is based on the 
-transfer complex between tetracyano
- electron 
t molar absorptivities (from 
s law is obeyed in the concentration ranges of 
-1 and 5–25µgmL–1, and the mean percent 
, 100.3±0.75 and 99.8±0.76 for amantadine 
[21]. 
r the determination of tranexamic acid 
al 
 
commercial 
 - 5,6-  
calculated and 
0.12µg/ml and 
d to be rapid, 
                        
 ethylene 
donors in the 
xes show 
2.1×103 to 
photo 
action of 
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 the drug with sodium 1,2-napthoquinone-4-sulphonate forming reddish 
orange colored chromogen with absorption maximum at 474nm. The 
chromogen obeyed linearity in the concentration range of 10-70 µg/ml[22].                                                                                                                              
- A rapid, simple, accurate and sensitive spectrophotometric method has 
been developed for the determination of tranexamic acid in bulk and 
pharmaceutical preparations. The method is based on the reaction of 
ninhydrin with the primary amino group of tranexamic acid in the basic 
medium at pH 8.0. The reaction produces a bluish-purple color which 
absorbs maximally at 565 nm. Beer's law was obeyed in the range of 3-40 
µg ml-1 with molar absorptivity of 5.093×103 Lmol-1cm-1. The effects of 
various factors such as temperature, heating time, concentration of reagent, 
color stability and interferences were investigated to optimize the procedure. 
The results have been validated analytically and statistically. The proposed 
method has been applied for the determination of tranexamic acid in bulk 
and pharmaceutical preparations with good results[23].                                                 
- A new spectrophotometric method has been developed for the 
simultaneous estimation of tranexamic acid and mefenamic acid in 
combined tablet dosage form based on derivatization with ninhydrin.  
Quantitative determination is performed by measuring the absorbance at two 
different wavelengths 571 nm and 335 nm. Beer’s law is obeyed in the 
concentration ranging from 8- 40µ g/mL for tranexamic acid and 4- 20 µ g/ml 
for mefenamic acid. The proposed method is validated for linearity, 
recovery, precision, robustness and specificity by statistical evaluation. 
Tranexamic acid and mefenamic acid calibration curves are linear with 
correlation coefficient of 0.9983 and 0.9991. Recovery is between 98.0% - 
101.0% for both tranexamic acid and mefenamic acid. The developed 
method can be used for routine quality control analysis of titled drugs 
combination in tablet formulation[24]. 
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 1.4. Spectrophotometry                                                                             
Quantitive analysis by UV/visible absorption spectrometry is practiced by 
almost every analytical laboratory. Most inorganic, organic and biochemical 
substances can be determined either directly or after the formation of an 
absorbing derivative or complex.      
In spectrophotometric analysis a source of radiation is used that extends into 
the UV/visible regions of the spectrum. Absorption of radiation in these 
regions of the electromagnetic spectrum results in electronic transitions 
between molecular orbitals. This corresponds to a wavelength range of 200-
800nm. The amount of absorbing radiation is proportional to concentration 
of absorbing substance and this is ruled by Beer’s law[25].  
All molecules can undergo electronic transitions, but in some cases 
absorption occurs below 200 nm, like saturated hydrocarbons. Unsaturated 
groups, known as chromophore, are responsible for absorption mainly in the 
near UV and visible regions and are of most value for quantitive analysis.  
The positions and intensities of the absorption bands are sensitive to 
substituent close to the chromophore, to conjugation with other 
chromophore and to solvent effects. Saturated groups containing hetero 
atoms which modify the absorption due to a chromophore are called 
auxochromes and include –OH,-CL,-OR and -NR2[25]. 
The chief advantage of spectrophotometric methods is that they provide a 
simple means for determining minute quantities of substances.   
1.4.1. Optimum conditions for assay by UV/visible spectrophotometer     
Points to be considered for a satisfactory colorimetric analysis include the 
degree of selectivity of a complexing agent (specificity of the colored 
reaction), stability of the color, clarity of the solution and effect of 
interfering substances[26]. 
In this connection the influence of other substances and experimental 
conditions such as temperature, pH, stability in air, organic solvent and order 
of mixing reagents must be known[26].  
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 1.4.2. Effect of solvent on absorption wavelength 
Solvents can induce significant changes in the intensity of band leading to 
either hyper chromic (increase in absorption intensity) or hypo chromic     
(decrease in absorption intensity) effect. In p ՜p * transitions, the absorption 
in a polar solvent will be at a longer wavelength than in a non-polar solvent 
and this is called red or bathochromic shift. The reverse is also observed in  
n՜p * transition and the bands shift to shorter wavelength due to the polar 
solvent. This is called blue or hypsochromic shift[27] (Figure1-2).  
 
 
 
 
 
Interaction between solute and solvent leads to absorption band broadening 
and a consequent reduction in structural resolution and ? max. Figure 1-3 
shows the effect of iso-octane and ethanol on the spectrum of phenol [28]. 
 
                                                                                                                             
1.4.3. Beer-Lambert’s law                                                                                           
The fundamental relationship used in spectrophotometry is known as Beer-
lambert’s law. A=A1%1cmൈbC. Where; A: absorbance of substance, A1% 1cm: 
absorptivity, b: cell path length (cm) &C: substance concentration (gm %).    
The deviation from Beer’s law could be due to instrumental (non-
monochromatic light, stray radiation and wide slit-width) or chemical effects 
(some absorbing compounds can undergo chemical changes like dissociation 
or association as a result of concentration variation)[25].  
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Figure (1-3): UV spectra of phenol in ethanol and in iso-octane. 
Figure (1-2): Effect of a polar solvent on p ՜p *& n ՜p * transitions. 
Non polar 
solvent 
Polar 
solvent E
N
E
R
G
Y  ݊
ߨכ 
ߨכ 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 1.4.4. Methods for calculation of the concentration                                         
To carry out an analysis of a known material it should be possible in theory 
to measure the absorption of a sample at itsabsorption maximum, measure 
the thickness of cell, obtain value of standard absorbtivity ሺߝሻ and then 
calculate the concentration [28]. Other procedure involves measurement the 
absorbance of a number (typically 4-6) of standard solutions, construction of 
a calibration graph and then determination of the sample concentration[28]. 
The single-point procedure involves the measurement of the absorbance of a 
sample solution and of a standard solution. Ideally, the concentration of the 
standard should be close to that of the sample [29].                                                                                                        
1.4.5. Irrelevant absorption  
This is unwanted absorption due to interferences from other constituents in a 
sample (impurities, decomposition products or formulation excipients) and if 
not removed, they lead to systematic error in the assay of a substance[25].  
 
                                                                                                                                                 
1.4.6. Standard addition method 
Most samples have many other components to the matrix that may interfere 
either chemically or physically. Recreating the exact environment to use the 
calibration curve method can be difficult and even impossible. Standard 
addition method is a good attempt around that. 
The method involves formation of one sample with unknown and a series of 
known with increasing volumes of added standard. A graph of absorbance 
against added standard concentration can be plotted and used to calculate the 
unknown concentration[30](Figure1-5).   
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Figure (1-5): Standard addition method curve.                                                                          
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Figure (1-4): Effect of interference on a true concentration of a substance.
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 1.4.7. Stoichiometry determination methods                                                     
Continuous variations method  
In this method (also called Job’s method) a series of solutions are prepared 
such that the total moles of metal and ligand in each solution are the same. 
The relative amount of ligand and metal in each solution is expressed as the 
mole fraction of ligand, (XL)i, and the mole fraction of metal, (XM)i. A plot 
of absorbance versus the mole fraction of ligand will show two linear 
branches. The intersection of these two branches occurs when a 
stoichiometric mixing of metal and ligand is reached[31](Figure1-6).    
 
 
 
 
 
  
 
Mole-ratio method  
In this method the moles of one reactant, usually the metal, are held 
constant, while the moles of the other are varied. A plot of absorbance as a 
function of the ligand-to-metal mole ratio has two linear branches that 
intersect at a mole ratio corresponding to the formula of the complex[31] 
(Figure1-7). 
 
 
 
 
 
 
                  
 
 
Slope-ratio method   
In this method two sets of solutions are prepared. The first set consists of a 
constant amount of metal and a variable amount of ligand (CL) while the   
second set of solutions is prepared with a fixed concentration of ligand and a 
variable concentration of metal (CM).  The mole ratio of ligand-to-metal is 
determined from the ratio of the two slopes of absorbance versus 
concentration plots[31].  
        
XL 
 
 
ML 
Moles ligand/Moles metal 
Figure (1-6): Continuous variation method curve  
reproduced from text book of modern analytical chemistry 
XL 
Figure (1-7): Mole ratio plot for 1:1 metal-ligand complex 
reproduced from text book of modern analytical chemistry 
 
A
bs
or
ba
nc
e 
A
bs
or
ba
nc
e 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 1.5. Chemistry of tranexamic acid & chromogenic reagents  
 
1.5.1. Tranexamic acid 
 
Tranexamic acid is a cyclohexane ring lacking conjugation. Thus, it is non 
UV/visible absorbing compound [6]. There are two geometric isomers for 4-
(aminomethyl) cyclohexane carboxylic acid. These are trans-isomer (1) and 
cis-isomer (2) [32]. The more thermodynamically stable is trans-isomer which 
is commercially known as tranexamic acid.  
 
    Trans-4-(aminomethyl) 
cyclohexane carboxylic acid
    cis-4-(aminomethyl)
cyclohexane carboxylic acid
O OH
NH 2
O OH
NH 2 (2)     (1)
 
 
Tranexamic acid exists in two conformations (I&II) and the kinetically 
stable cis-isomer also exists in two conformations (III&IV). Chair 
conformation of cyclohexane demonstrates that the more stable conformer 
(lowest energy) is that having both substituents (-NH2 ,-COOH) in equatorial 
positions because the two functional groups are furthest from each other. 
 
COOH
H 2 N
COOH
H 2 N
 
 
 
1-trans (equatorial,equatorial)1-trans (axial,axial)
(I) (II)
 
COOH
H 2 N
COOH
H 2 N
 
2-cis(equatorial,axial) 2-cis(axial,equatoral)
(III) (IV)  
 
1.5. 2. Chemical synthesis of tranexamic acid 
 
Literature revealed different synthetic routes for tranexamic acid. For 
example, tranexamic acid could be prepared starting form p-amino methyl 
benzoic acid (A). Syn reduction of the aromatic ring in (A) using platinum 
as catalyst gives the cis-isomer of 4-(aminomethyl)cyclo hexane carboxylic 
acid (B) which is thermodynamically unstable[32](Scheme 1-1).     
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 CH2NH2
COOH COOH
CH2NH2
 (B)  (A)  
 
 
Heating cis-isomer (2) under nitrogen at 315-325oC results in epimerization 
of the carboxylic group yielding the thermodynamically stable and 
pharmacologically active trans-isomer [32]. 
 
1.5.3. Gibb’s reagent 
 
The 2,6-dichloroquinine-4-chlorimide, commercially known as Gibb’s 
reagent, is an electrophilic compound with nitrogen being the electrophilic 
center. Therefore, it usually undergoes nucleophilic substituation reaction 
with nucleophiles such as R-SH, R-NH2.    
 
NO
Cl
Cl
Cl
 
  2,6-dichloroquinine-4-chlorimide(DCQ) 
 
Literature revealed that drugs containing either –SH or -NH2 could be 
assayed spectrophotometrically using DCQ as chromogenic reagent. For 
example, captopril[33] and D-penicillamine[34](thiol containind drugs) react 
with DCQ to give colored products according to the following scheme[34].  
 
 DCQ
     Thiol
RHS ClH+O N Cl
Cl
Cl
SR
Cl
Cl
O N +
 
Scheme (1-2): Reaction between DCQ and thiol 
                                                
HO
NH2
SH
O
CH3H3C
  
Scheme (1-1): Chemical synthesis of tranexamic acid. 
 
N
COOHO
HS
H CH3
d  + d  - 
D-penicillamine                       Captopril                                       
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 DCQ also reacts similarly with primary amine containing drugs (Scheme1-3) 
such as pregabalin[35] and methyl dopa[36] . 
DCQ
RH2N ClHO N Cl
Cl
Cl
NHR
Cl
Cl
O N + +
  Amine
                                                                 
Scheme (1-3): Reaction between DCQ and amine. 
O
OH
NH2
     
NH 2
HO
HO
COOH
CH 3
 
                                     Pregabalin                           Methyl dopa 
 
Chromophores resulting from reaction of DCQ with thiol containing drugs 
and DCQ with primary amine containing drugs are absorbed around 400nm. 
      
Drug Nucleophile ? max. 
Captopril       -SH 443 
D-penicillamine       -SH 431 
Pregabalin -NH2 400 
Methyl dopa -NH2 400 
 
1.5.4. Reaction of amines with carbonyl compounds                               
Imines are formed when any primary amine reacts with an aldehyde or a 
ketone under appropriate conditions. First, amine attacks the carbonyl group 
and the intermediate is formed (hemiaminal), dehydration then gives the 
imine[37] (Scheme 1-4). 
HR
O
R1H2N NR
O
H H
R1
NR
OH
R1
H
 
H
NR
OH2
R N
R1
HH
R1 R N
R1
 
Scheme (1-4): Reaction between amine and carbonyl compounds 
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 It’s important to notice that acid is not needed for the addition step in the 
mechanism (indeed, protonation of the amine means that this step is very 
slow in strong acid), but is needed for the elimination of water later on in the 
reaction. Imine formation is in fact fastest at about pH 4–6; at lower pH, too 
much amine is protonated and the rate of the first step is slow; above this pH 
the proton concentration is too low to allow protonation of the -OH leaving 
group in the dehydration step. Imine formation is like a biological reaction; 
it is fastest near neutrality [37] (Figure 1-8). 
 
 
 
 
 
 
 
 
Figure (1-8): Variation of rate of imine formation with pH. 
Imines are unstable with respect to their parent carbonyl compound and 
amine and must be formed by a method that allows removal of water from 
the reaction mixture. However, imines in which the nitrogen atom carries an 
electronegative group are usually stable.   
In general, they are only stable enough to isolate if either the C or N of the 
imine double bond bears an aromatic substituent. Imines formed from 
ammonia are unstable, but can be detected in solution. CH2=NH, for 
example, decomposes at temperatures above –80 °C, but PHCH=NH is 
detectable by UV spectroscopy in a mixture of benzaldehyde and ammonia 
in methanol[37] (Scheme 1-5).  
CHO
    +    
NH +    
ammonia Imine waterbenzaldehyde                                                                                                  
Scheme (1-5): Reaction between benzaldehyde and ammonia. 
 
Rate determining 
addition.  
Rate determining 
dehydration. 
pH 
Log rate 
5-6 
NH3 H2O 
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 1.5.5. Ascorbic acid 
Ascorbic acid (vitamine C) is a naturally occurring organic compound. It 
usually acts as an antioxidant; typically reacts with the reactive oxygen 
species such as the hydroxyl radical formed from hydrogen peroxide[ϯϴ]. 
 
O O
HO OH
HO
H
HO
 
L-ascorbic acid. 
(5R)-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one. 
 
As a mild reducing agent, ascorbic acid (I) degrades upon exposure to air, 
converting the oxygen to water. The redox reaction is accelerated by the 
presence of metal ions and light. It can be oxidized by one electron to a 
radical state or doubly oxidized to the stable form called dehydroascorbic 
acid (II) [ϯϴ].     
O O
HO OH
HO
H
HO O O
HO
H
HO
O O(I) (II)
   Reduced form
     Ascorbic acid
Oxidized form
Dehydro ascorbic acid  
  
Thus, the oxidized form of ascorbic acid can act like ketone when react with 
amine producing conjugating compound (Scheme 1-6). Literature revealed 
that there is number of primary amine containing drugs react with ascorbic 
acid producing suitable chromophore for UV/visible assay such as 
alfuzocin[39], lisinopril[40] and tobramycin[41]. 
 
R1H2N R1 +  H2O. +     
O
O
R
O
O
O
N
R
O
O
Dehydro ascorbic acid primary amine imnie water
   
                Scheme (1-6): Reaction between dehydro ascorbic acid and primary amine 
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               Alfuzocin                                              Lisinopril                              Tobramycin 
 
Chromophores resulting from reaction of ascorbic acid with primary amine 
containing   drugs are absorbed at 530nm.   
   
Drug Nucleophile ? max. 
Alfuzocin -NH2 530 
Lisinopril -NH2 530 
Tobramycin -NH2 530&390 
 
1.5.6. Reaction of ninhydrin with amine  
 
Reaction of ninydrin (I) with amine results in formation of Ruheman purple 
(V) after dehydration of ninhydrin to 1,2,3-indantrione(II)[42](Scheme 1-7). 
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O
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-H2O
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H
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Ruhemann's purple                                     
Scheme (1-7): Reaction of ninhydrin with amine. 
The aqueous solutions of amine react with ninhydrin in the pH range 5-7 to 
form Ruhemann’s purple with molar ratio 1:2 respectively. The reaction is 
first order in ninhydrin, first order in amino acid, and second order 
overall[42]. 
The primary amino group of tranexamic acid was found to be capable to 
react with compound containing carbonyl group like ninhydrin and the 
resulting bluish-purple colored complex absorbs maximally at 565nm[23 ]. 
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 2. OBJECTIVES 
 -To develop two new spectrophotometric methods for determination of 
tranexamic acid.  
-To study various experimental parameters affecting color development and 
stability.    
-To validate the suggested procedures via analytical and statistical 
evaluations. 
-To test the ability of the proposed methods for determination of tranexamic 
acid in different pharmaceutical formulations.    
-To study the reaction kinetics of both developed methods to stimulate 
additional ways for calculation of tranexamic acid concentration.  
-To study the reaction stoichiometry for each method to provide help in the 
suggestion of reaction mechanism.  
- To compare these developed methods with official and other reported 
methods used for assay of tranexamic acid to identify the advantages that the 
proposed procedures have to offer.  
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 3. MATERIALS & METHODS 
 3.1. Materials                                                                                        
The materials used and their sources were summarized in the following 
table.                                                                                                                    
3.1.1. Drugs 
 Table (3-1): Drugs                                                                                                               
Chemical Company  Country  
TREXAMIN ®  capsules 
Tranexamic acid 250mg/capsule 
Batch No: 8838   
Registration No:000408EX 
Manufacturing date:6/08 
Expiration date :6/12 
Hilton pharma  
(pvt.) Ltd 
Pakistan 
Tranexamic acid Powder(standard) 
Potency:100.00% 
Expiration date:10/11/2015 
National drug quality 
control laboratory 
Sudan 
 
3.1.2. Reagents                                                                                             
Table (3-2): Reagents  
Chemical                                                                                                                              Company Country
 L-ascorbic acid.LR.99% S.d.fine-chem limited   India  
2,6- dichloroquinone-4-chlorimide 
(DCQ).GR.99%. 
Lobal chemie India 
Dimethyl sulphoxide  AR.99.5%  S.d.fine-chem limited   India  
Methanol for HPLC.99.8% Lobal chemie India 
 
3.1.3. Instruments and apparatus 
1. UV-1800 ENG 240 V, Shimadzu UV spectrophotometer, Japan.                              
2. Electronic balance, A ൈ 120, Shimadzu, Japan.                                              
3. Water Bath, Gesellschaft fur Labor techink (GFL), 1032, Germany.  
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 3.2. Methods 
3.2.1. Tranexamic acid with DCQ  
Materials & reagents                                                                                              
The following solutions were prepared. 
Stock solution of standard tranexamic acid  
0.025g of tranexamic acid was accurately weighed and transferred into 25 
ml volumetric flask. About 20 ml of distilled water was added and then the 
solution was shaken for 15 minutes to ensure dissolution. Then the volume 
was completed to 25ml with water. The final concentration of this solution 
(solution A) is 1000µg/ml (0.1% w/v).    
 Stock solution of tranexamic acid capsules  
A mass of the powdered sample equivalent to 0.025g of tranexamic acid was 
accurately weighed and transferred into 25 ml volumetric flask. About 20 ml 
of distilled water was added and the solution was shaken for 15 minutes to 
ensure dissolution. 
The volume was completed to mark with distilled water, mixed and then 
filtered. The final concentration of this solution (solution B) is 1000µg/ml 
(0.1% w/v).  
Solution of coupling reagent  
0.025g of DCQ was transferred into 10ml volumetric flask. About 8ml of 
methanol was added and the solution was shaken for 15 minutes to ensure 
dissolution .The volume was then completed to mark with methanol. The 
final concentration of this solution (solution C) is 0.25% w/v.  
Methods & experiments.                                                                                        
3.2.1.1. Estimation of ? max.                                                                                     
3.2.1.1.1. Estimation of ? max.of colored complex 
To 1.5ml of solution A in stoppered glass tube, a volume of distilled water 
was added to adjust the volume to 2.5ml. Five ml of dimethyl sulfoxide 
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 (DMSO) followed by 0.7ml of freshly prepared solution C were added and 
the volume was completed to 10ml using water, in which the final solution 
contains 150µg/ml tranexamic acid.  
The solution was heated for 3 minutes in a boiling water bath and allowed to 
cool at room temperature. Blank was prepared similarly but without using 
solution A. UV/visible spectrophotometer was run in scanning mode from 
350-750nm using above solution against blank. 
3.2.1.1.2. Estimation of ? max of DCQ under the same experimental 
conditions               
To 2.5ml of distilled water in stoppered glass tube, five ml of DMSO and 
0.7ml of freshly prepared solution C were added. The volume was then 
completed to 10ml by water and heated for three minutes in a boiling water 
bath.  
A blank was prepared similarly using 0.7ml methanol instead of solution C. 
After cooling to room temperature, the solution was scanned (200-800nm) 
against its blank.   
 3.2.1.2. Reaction conditions optimization 
3.2.1.2.1. Effect of heating 
Non-heating method                                                                                         
Serial dilutions were made from 0.1%w/v aqueous tranexamic acid solution. 
0.5, 1, 2 and 2.5ml of this solution were transferred into stoppered glass 
tubes and then 2, 1.5, 0.5and 0.0ml of distilled water were added to each 
tube respectively. Five ml of DMSO followed by 0.7ml of 0.25%w/v 
solution of DCQ in methanol were added to each tube. The volumes were 
then completed to 10 ml with distilled water and were heated for 3minutes in 
a boiling water bath.                          
After cooling to room temperature, each solution was measured at 670nm 
against blank  every 15 minutes starting from 45 minutes (the reaction is 
very slow) till 150 minutes in order to estimate the time that give maximum 
color intensity.     
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 Heating method                                                                                                  
The same was done as above method but instead of measuring every 15 
minutes, the solutions were heated in a boiling water bath for three and for 
five minutes then measured immediately after cooling at room temperature.   
3.2.1.2.2. Effect of solvent  
Effect of solvent type 
0.3ml of 0.024%w/v aqueous tranexamic acid solution was transferred into 
stoppered glass tube and the volume was completed to 2ml with distilled 
water. One ml of 10% w/v aqueous solution of sodium acetate followed by 
1ml of 0.4% w/v solution of DCQ in DMSO were added. Then, the volume 
was completed to 10ml by DMSO.  
The same was done as above procedure but the volume was completed with 
water instead of DMSO. Then the absorbance of each solution was measured 
after one hour against reagent blank at 670nm. 
Effect of solvent volume (DMSO) 
Serial dilutions were made from 0.024% w/v aqueous tranexamic acid 
solution. 0.1, 0.3 and 0.5ml of this solution were transferred into stoppered 
glass tubes and then the volume was completed to 2ml in each with distilled 
water. One ml of 10% w/v aqueous solution of sodium acetate followed by 
1ml of 0.4% w/v solution of DCQ in DMSO were added to each tube. After 
waiting one hour at room temperature, the volume was completed to 10 ml 
by DMSO. 
The same procedure was done as above except the volume was completed 
before waiting one hour. Then the absorbance of two sets of solutions was 
measured against reagent blank at 670nm.  
3.2.1.2. 3. Effect of coupling reagent concentration  
In absence of sodium acetate 
In three stoppered glass tubes containing 2ml of 0.1%w/v aqueous 
tranexamic acid solution, 0.5ml of water followed by 5ml of DMSO were 
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 added to each tube. Then, 0.7ml of 0.1%, 0.25% & 0.5%w/v solutions of 
DCQ in methanol were added to the first, second and third tube, 
respectively. These volumes were completed to 10ml by water and heated in 
a boiling water bath for three minutes. After cooling to room temperature, 
the absorbance was measured at 670nm against blank.  
 In presence of sodium acetate  
0.1ml & 0.5ml of 0.03%w/v aqueous tranexamic acid solution were 
transferred into two stoppered glass tubes. The volume was then completed 
to 2ml in each tube with water. 6ml of DMSO followed by 0.4ml of 1%w/v 
aqueous solution of sodium acetate were added. 0.2ml of 0.5%w/v solution 
of DCQ in DMSO was added to each tube and the volume was completed to 
10ml by DMSO. After waiting one hour at room temperature, the 
absorbance was measured at 670nm against blank.  
The same was done as above but with using 0.8%w/v solution of DCQ in 
DMSO in place of 0.5%.  
3.2.1.2.4. Effect of alkaline media 
0.1ml & 0.5ml of 0.12% w/v aqueous tranexamic acid solution were 
transferred into two stoppered glass tubes. The volume was completed to 
2ml by water in each. 6ml of DMSO followed by 0.4ml of 10% w/v aqueous 
solution of sodium acetate were added. Then, 0.2ml of 0.5% w/v solution of 
DCQ in DMSO was added to each tube and the volume was completed to 
10ml by DMSO. The absorbance was measured against blank at 670nm at 
different time intervals.  
The same procedure was done as above using 1ml of 0.12% w/v aqueous 
tranexamic acid solution and 0.4ml of 1% w/v aqueous solution of sodium 
acetate. In the third part of experiment also the same was done but with out 
using sodium acetate.                                                                                                                
3.2.1.2.5. Estimation of color stability                                                                 
Two ml of freshly prepared solution A was transferred into stoppered glass 
tube. A volume of distilled water was added to adjust the volume to 2.5ml 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 and 5ml of DMSO followed by 0.7ml of freshly prepared solution C were 
added. The solution was heated for 3 minutes in a boiling water bath and 
allowed to cool at room temperature then the absorbance was measured at 
different time intervals to check the stability of colored complex. Blank was 
prepared similarly but without solution A.    
3.2.1.3. Validation of the proposed method 
3.2.1.3.1. Construction of calibration curve                                                           
Serial dilutions were made from solution A. 0.5, 1, 1.5, 2 and 2.5ml of this 
solution were transferred into stoppered glass tubes and then 2, 1.5, 1, 0.5 
and 0.0ml of distilled water were added to each tube respectively. Five ml of 
DMSO followed by 0.7ml of freshly prepared solution C were added to each 
tube. The volumes were then completed to 10ml with distilled water and 
were heated for 3 minutes in a boiling water bath.   
Blank was prepared in the same manner using 2.5ml water instead of 2.5 ml 
of solution A.  
After cooling to room temperature, the UV/visible spectrophotometer was 
run in scanning mode from 600-800nm and the absorbance of each solution 
was measured against the blank. This procedure was repeated four times to 
obtain four readings of standard curves. 
3.2.1.3.2. Construction of tranexamic acid sample curve                              
Serial dilutions were made from solution B. 0.5, 1, 1.5, 2 and 2.5ml of this 
solution were transferred into stoppered glass tubes and then 2, 1.5, 1, 
0.5and 0.0ml of distilled water were added to each tube respectively. Five ml 
of DMSO followed by 0.7ml of freshly prepared solution C were added to 
each tube. These volumes were then completed to 10 ml with distilled water 
and were heated for 3 minutes in a boiling water bath   
Blank was prepared in the same manner using 2.5ml water instead of 2.5 ml 
of solution A. After cooling to room temperature, the UV/visible 
spectrophotometer was run in scanning mode from 600-800nm and the 
absorbance of each solution was measured against the blank to compare the 
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 UV/visible absorption pattern with that of the standard. This procedure was 
repeated four times to obtain four readings of standard curves.                                                                                
3.2.1.3.3. Repeatability and reproducibility of the method                      
0.5, 1, 1.5, 2and 2.5ml of freshly prepared solution A were transferred into 
stoppered glass tubes. A volume of distilled water were added to adjust the 
volume to 2.5ml and 5ml of DMSO followed by 0.7ml of freshly prepared 
solution C were added to each tube. The volumes were then completed to   
10ml with distilled water. These solutions were then heated for 3 minutes in 
a boiling water bath and allowed to cool at room temperature. The 
absorbance was measured against blank that was prepared similarly but 
without using solution A at 670 nm.  
The method was repeated three times within day in order to evaluate the 
repeatability of the method and in three consecutive days in order to evaluate 
the reproducibility of the method using fresh solution A.    
3.2.1.3.4. Added recovery (%) measurement                                                        
The following solutions were prepared.                                                         
Standard                                                                                                              
One ml from solution A was transferred into stoppered glass tube. 1.5ml of 
distilled water and 5ml of DMSO followed by 0.7ml of freshly prepared 
solution C were added. The volume was then completed to 10ml by distilled 
water (tube 1).                                                                                                   
Capsules                                                                                                              
The same procedure was used using solution B in place of solution A(tube2).       
Mixture                                                                                                                  
To 1ml of solution A, 1ml of solution B, 0.5 ml of distilled water and 5ml of 
DMSO were added. Then the addition of 0.7ml of freshly prepared solution 
C and completion of the volume to 10ml by water were made (tube 3).                                                                                                
Blank                                                                                                                                
To 2.5ml of water, 5ml of DMSO and 0.7ml freshly prepared solution C 
were added and the volume was completed to 10ml with distilled water.    
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 All of these solutions were heated in a boiling water bath for 3 minutes and 
allowed to cool at room temperature. The absorbance was then measured at 
670nm and the procedure was repeated three times.                                                                                      
3.2.1.3.5. Standard addition method                                                              
One ml of solution B was transferred into four stoppered glass tubes.  Then, 
aliquot volumes (0, 0.5, 1, and 1.5ml) of solution A followed by a volume of 
distilled water were added to each tube to adjust the volume to 2.5ml.Then 
5ml of DMSO and 0.7ml of freshly prepared solution C were added. The 
volumes were then completed to 10 ml with distilled water (Table 3-3).       
These solutions were heated for 3 minutes in a boiling water bath and 
allowed to cool at room temperature. Blank was prepared similarly but 
without using solution A and B. The absorbance was measured against blank 
at 670 nm and was plotted against the concentration of solution A in order to 
obtain standard addition method graph.                      
Table (3-3): Tranexamic acid aliquot solutions for standard addition method  
Solution 
No. 
Solution 
B (ml) 
Solution  
A (ml) 
Water 
(ml) 
DMSO 
(ml) 
Solution 
C  (ml) 
Water 
(ml) 
Conc. * 
(µg/ml) 
1 1 0 1.5 5 0.7 1.8 0 
2 1 0.5 1 5 0.7 1.8 50 
3 1 1 0.5 5 0.7 1.8 100 
4 1 1.5 0 5 0.7 1.8 150 
Blank 0 0 2.5 5 0.7 1.8 0 
*Theoretical standard tranexamic acid concentration. 
3.2.1.3.6. Assay of tranexamic acid                                                                  
(Direct standard /sample comparison)                                                              
Capsules                                                                                                                 
To 1, 1.5&2.5ml of solution B, 1.5, 1&0ml of distilled water were added 
respectively. 5ml of DMSO and then 0.7ml of freshly prepared solution C 
were added and the volumes were completed to 10ml with distilled water.                                  
Standard                                                                                                         
To1, 1.5&2.5ml of solution A, 1.5, 1&0ml of distilled water were added. 
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 5ml of DMSO and then 0.7ml freshly prepared solution C were added and 
the volumes were completed to 10ml with distilled water. 
Blank                                                                                                                     
To 2.5ml of water, 5ml of DMSO and 0.7ml freshly prepared solution C 
were added and the volume was completed to 10ml with distilled water. 
The three solutions were then heated for 3 minutes in a boiling water bath   
and allowed to cool at room temperature. The absorbance of both the sample 
and standard were measured at 670nm against the blank and the content 
percent was calculated. This procedure was repeated 4 times to obtain 4 
readings of both.   
3.2.1.4. Kinetic study of tranexamic acid-DCQ complex reaction  
Serial dilutions were made from solution A. 0.5, 1, 2 and 2.5ml of this 
solution were transferred into stoppered glass tubes and then 2, 1.5, 0.5 and 
0.0ml of distilled water were added to each tube respectively. Addition of 
5ml DMSO, 0.7ml freshly prepared solution C and completion of the 
volumes to 10ml with distilled water were made in each tube.                                              
Blank was prepared in the same manner using 2.5ml water instead of 2.5 ml 
of solution A (Table 3-4).  
Then, the absorbance of each solution was measured at 670nm every 15 
minutes starting from 45 minutes to 150 minutes to study the effect of time 
on absorbance value. A graph of absorbance against time of different 
concentration was plotted and the kinetic parameters were calculated.                                         
Table (3-4): Tranexamic acid solutions for kinetic study 
Solution 
No. 
Solution 
A(ml) 
Water 
(ml) 
DMSO 
(ml) 
Solution 
C (ml) 
Water 
(ml) 
Concentration* 
( µg/ml) 
1 0.5 2.00 5 0.7 1.8 50 
2 1.00 1.5 5 0.7 1.8 100 
3 2.00 0.5 5 0.7 1.8 200 
4 2.5 0.00 5 0.7 1.8 250 
*Tranexamic acid in final concentration 
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 Fixed absorption time method                                                                  
0.5, 1, 1.5, 2 and 2.5ml of solution A were transferred into stoppered glass 
tubes and volumes of distilled water were added to adjust the volumes to 
2.5ml.  Five ml of DMSO and 0.7ml of freshly prepared solution C were 
added to each tube. The volumes were then completed to 10 ml with distilled 
water. The final solutions contain 50, 100, 150, 200, and 250µg/ml of 
tranexamic acid respectively.                                                                                                                       
Blank was prepared similarly but without using solution A and the 
absorbance was measured against blank at 670 nm for each concentration at 
different time intervals. The time at which each concentration of tranexamic 
acid required to attain a fixed absorption value was recorded.  
 3.2.1.5. Comparing TA-DCQ spectrophotometric method with official 
titrimetric method   
3.2.1.5.1. Assay of tranexamic acid capsule using official titrimetric 
method                                             
A mass of the powdered sample equivalent to 0.05g of tranexamic acid was 
accurately weighed and dissolved in 20ml distilled water. Then was    
shaken for 15minutes and transferred into 250ml conical flask without 
filtration. 10ml of formaldehyde solution was added after neutralization with 
sodium hydroxide using phenolphthalein as indicator (slight pink). Then it 
was mixed and titrated with 0.5N sodium hydroxide. The end point was 
determined by formation of stable slight pink color in presence of 
phenolphthalein as indicator. This procedure was repeated three times and 
the content percent was calculated.   
3.2.1.5.2. Assay of tranexamic acid capsule using TA-DCQ 
spectrophotometric method  
The same methods mentioned in section3.2.1.2.6.             
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 3.2.1.6. Molar ratio method for determination of the stoichiometry     
(Fixed DCQ concentration and varied tranexamic acid concentrations)         
0.0768g of standard tranexamic acid powder was dissolved in 20ml water 
(concentration 24 ൈ 10-3 M). 0.5,0.75,1,1.25,1.5,1.75 and 2ml of this 
standard solution were transferred to seven stoppered glass tubes and then 
2,1.75,1.5,1.25,1,0.75 and 0.5ml of distilled water were added respectively. 
Five ml of DMSO and one ml of freshly prepared solution of DCQ in 
methanol (12 ൈ 10-3 M) were added to each tube. The volumes were then 
completed to 10 ml with distilled water.  
Solutions were heated for 3 minutes in a boiling water bath and allowed to 
cool at room temperature. The absorbence of the resulting solutions were 
measured against the blank at 670nm.                
The blank was prepared in the same manner with replacement of the 
standard solutions volume by distilled water. The molar ratio of the reaction 
complex was obtained from a plot of tranexamic acid over DCQ molar ratio 
Vs absorbence (Table3-5).                                           
Table (3-5): Tranexamic acid aliquot solutions for molar ratio method  
Solution 
No. 
Standard 
solution 
(ml) 
Water 
(ml) 
DMSO 
(ml) 
DCQ 
(ml) 
Water 
(ml) 
Conc.* 
(M) 
Molar 
ratio 
TA/DCQ 
1 0.5 2.00 5 1 1.5 1.2ൈ 10-3 1 
2 0.75 1.75 5 1 1.5 1.8ൈ 10-3 1.5 
3 1.00 1.5 5 1 1.5 2.4ൈ 10-3 2 
4 1.25 1.25 5 1 1.5 3.0ൈ 10-3 2.5 
5 1.5 1.00 5 1 1.5 3.6ൈ 10-3 3 
6 1.75 0.75 5 1 1.5 4.2ൈ 10-3 3.5 
7 2.00 0.5 5 1 1.5 4.8ൈ 10-3 4 
*Final tranexamic acid concentration.                                      
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 3.2.2. Tranexamic acid with L-ascorbic acid                                                          
Materials & reagents                                                                                                  
The following solutions were prepared.                                                                
Stock solution of standard tranexamic acid                                       
0.0125g of tranexamic acid was accurately weighed and transferred into 
25ml volumetric flask. About 20ml of distilled water was added and then the 
solution was shaken for 15minutes to insure dissolution. Then the volume 
was completed to 25ml with water. The final concentration of this solution 
(solution A) is 500µg/ml (0.05%w/v).                                                                                                     
Stock solution of tranexamic acid capsules  
A mass of the powdered sample equivalent to 0.0125g of tranexamic acid 
was accurately weighed and transferred into 25 ml volumetric flask. About 
20 ml of distilled water was added and the solution was shaken for 15 
minutes to ensure dissolution .The volume was completed to mark with 
distilled water, mixed and then filtered. The final concentration of this 
solution (solution B) is 500µg/ml (0.05% w/v).  
Solution of coupling reagent  
0.2g of ascorbic acid was transferred into 10ml volumetric flask. About 
0.5ml of water plus 6.5ml of DMSO were added and the solution was shaken 
for 15 minutes. The volume was then completed to mark with DMSO. The 
final concentration of this solution (solution C) is 2% w/v.  
Methods and experiments                                                                            
3.2.2.1. Estimation of ? max. 
3.2.2.1.1. Estimation of ? max. of colored complex 
To 0.5ml of solution A in stoppered glass tube, one ml of freshly prepared 
solution C followed by 3ml of DMSO were added. The solution was then 
heated in a boiling water bath for 45 minutes and allowed to cool at room 
temperature.  
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 The volume was completed to 10ml using DMSO in which the final solution 
contains 25µg/ml of tranexamic acid. Blank was prepared similarly but 
without using solution A. UV/visible spectrophotometer was run in scanning 
mode from 300nm-700nm using above solution against its blank. 
3.2.2.1.2Estimation of? max of ascorbic acid under the same experimental 
conditions                                                                                                           
To 0.5ml of distilled water in stoppered glass tube, one ml of solution C and 
3ml of DMSO were added. Then, the solution was heated in a boiling water 
bath for 45minutes and allowed to cool at room temperature. The volume 
was then completed to 10ml using DMSO and scanned    (200nm-800nm) 
against blank that was prepared similarly with replacing the volume of 
solution C by DMSO.       
3.2.2.2. Reaction conditions optimization 
3.2.2.2.1. Effect of heating 
Serial dilutions were made from 0.05%w/v aqueous tranexamic acid 
solution. 0.2, 0.3, 0.4 and 0.5ml of this solution were transferred into 
stoppered glass tubes and then 0.3, 0.2, 0.1and 0.0ml of distilled water were 
added to each tube respectively. Addition 1ml of 2%w/v solution of ascorbic 
acid in DMSO and 3ml of DMSO were made to each tube.                                                                                                           
These solutions were then heated in a boiling water bath for different time 
intervals (10, 15, 20, 25, 30, 40, 45 and 50 minutes) to study the effect of 
time on maximum color development. After cooling to room temperature, 
these volumes were completed to 10ml with DMSO and the absorbance was 
measured against blank. 
3.2.2.2.2. Effect of solvent  
Effect of solvent type 
0.3ml of 0.12% w/v aqueous tranexamic acid solution was transferred into 
stoppered glass tube. Then the volume was completed to 0.5ml with water. 
One ml of 2%w/v solution of ascorbic acid in DMSO followed by 3ml of 
DMSO were added. After heating 40minutes in a boiling water bath, the 
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 solution was allowed to cool at room temperature and the volume was 
completed to 10ml by DMSO.    
The same procedure was repeated with using water as solvent instead of 
DMSO.  
Effect of solvent volume 
To 0.1, 0.3 and 0.5ml of 0.12% w/v aqueous tranexamic acid solution, 0.4, 
0.2 and 0.0ml of water were added. One ml of 2% w/v solution of ascorbic 
acid in DMSO followed by 3ml of DMSO were added to each tube. After 
heating 40minutes in a boiling water bath, the solutions were allowed to cool 
at room temperature and the volume was completed to 10ml by DMSO. The 
absorbance of each solution was then measured against blank at 530 and 
390nm.   
The same procedure was repeated with volume completion before heating.  
3.2.2.2.3. Effect of ascorbic acid in different solvents  
Ethanol and isopropanol 
0.1, 0.3 and 0.5ml of 0.4% w/v aqueous tranexamic acid solution were 
transferred into three stoppered glass tubes.  These volumes were then 
completed to 0.5ml by water. 1ml of 2% w/v solution of ascorbic acid in 
ethanol followed by 3ml DMSO were added to each tube. These solutions 
were heated in a boiling water bath for 45minutes and after cooling to room 
temperature the volumes were completed to 10ml by DMSO. The 
absorbance was measured against blank at 530 and 390nm.  
The same was done as above with using 2% w/v solution of ascorbic acid in 
isopropanol.  
Isopropanol and DMSO 
0.1, 0.2, 0.3, and 0.6ml of 0.1% w/v aqueous tranexamic acid solution were 
transferred into four stoppered glass tubes. These volumes were then 
completed to 0.6ml by water. 1ml of 2% w/v solution of ascorbic acid in 
isopropanol followed by 3ml DMSO were added to each tube. These 
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 solutions were heated in a boiling water bath for 45minutes and after cooling 
to room temperature the volumes were completed to 10ml by DMSO. The 
absorbance was measured against blank at 530 and 390nm.  
The same was done as above with using 2% w/v solution of ascorbic acid in 
DMSO.  
3.2.2.2.4. Effect of mixing order  
0.1, 0.2, 0.3, 0.4 and 0.5ml of 0.12% w/v aqueous tranexamic acid solution 
were transferred into five stoppered glass tubes. These volumes were then 
completed to 0.5ml by water. 1ml of 2% w/v solution of ascorbic acid in 
DMSO followed by 3ml DMSO were added to each tube. These solutions 
were heated in a boiling water bath for 45minutes and after cooling to room 
temperature the volumes were completed to 10ml by DMSO. The 
absorbance was measured against blank at 530 and 390nm.  
The same was done as above but with addition of DMSO before ascorbic 
acid.  
3.2.2.2.5. Effect of ascorbic acid concentration 
In three stoppered glass tubes containing 0.5ml of 0.05% w/v aqueous 
tranexamic acid solution, 1ml of 1%, 2% and 3% w/v solutions of ascorbic 
acid in DMSO were added to the first, second and third tube, respectively.  
Then, 3ml of DMSO were added to each tube and the solutions were heated 
in a boiling water bath for 45minutes.  After cooling to room temperature the 
volumes were completed to 10ml by DMSO and the absorbance was 
measured against blank at 530 and 390nm.  
3.2.2.2.6. Estimation of color stability                                                               
0.4ml of freshly prepared solution A was transferred into stoppered glass 
tube. A volume of distilled water was added to adjust the volume to 0.5ml 
followed by addition of 1ml freshly prepared solution C and 3ml of DMSO. 
This solution was heated in a boiling water bath for 45minutes and allowed 
to cool at room temperature.  
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 The volume was then completed to 10ml using DMSO (the final solution 
contain 20µg/ml tranexamic acid) and the absorbance was measured against 
blank that was prepared similarly but without using solution A at different 
time intervals to check the stability of the formed colored complex.    
3.2.2.3. Validation of the proposed method 
3.2.2.3.1. Construction of calibration curve                                                     
0.2, 0.3, 0.4&0.5ml of solution A were transferred into four stoppered glass 
tubes and then 0.3, 0.2, 0.1 &0.0ml of distilled water were added to each 
tube respectively. One ml of solution C followed by 3ml of DMSO were 
added to each tube. These solutions were then heated in a boiling water bath 
for 45 minutes and allowed to cool at room temperature. The volume was 
completed to 10ml in all using DMSO.  
UV/visible spectrophotometer was run in scanning mode from 300nm-
700nm and the absorbance of each solution was measured against the blank. 
This procedure was repeated four times to obtain four readings of standard 
curves.     
3.2.2.3.2. Construction of tranexamic acid sample curve                                     
0.2, 0.3, 0.4and 0.5ml of solution B were transferred into stoppered glass 
tubes and then 0.3, 0.2, 0.1 and 0.0ml of distilled water were added to each 
tube respectively. One ml of solution C followed by 3ml of DMSO were 
added to each tube. These solutions were then heated in a boiling water bath 
for 45 minutes and allowed to cool at room temperature. The volume was 
completed to 10ml in all using DMSO.  
Blank was prepared in the same manner using 0.5ml of water instead of 
0.5ml of solution B.UV/visible spectrophotometer was run in scanning mode 
from 300nm-700nm and the absorbance of each solution was measured 
against the blank to compare the UV/visible absorption pattern with that of 
the standard. This procedure was repeated four times to obtain four readings 
of standard curves. 
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 3.2.2.3.3. Repeatability and reproducibility of the method    
0.2, 0.3, 0.4 and 0.5ml of freshly prepared solution A were transferred into 
stoppered glass tubes. A volume of distilled water was added to adjust the 
volume to o.5ml in all. One ml of freshly prepared solution C and 3ml of 
DMSO were added to each tube. The volume was then completed to10ml 
using DMSO after heating in a boiling water bath for 45 minutes and cooling 
to room temperature. The final solutions contain 10, 15, 20, 25µg/ml 
respectively.                                                                                           
Blank was prepared similarly but without using solution A and the 
absorbance of all was measured against this blank. This method was 
repeated three times within day in order to evaluate the repeatability and in 
three consecutive days in order to evaluate the reproducibility of the method.                                                                                                      
3.2.2.3.4. Added recovery (%) measurement                                                        
The following solutions were prepared.                                                        
Standard                                                                                                             
0.2ml from solution A was transferred into stoppered glass tube. 0.3ml of 
distilled water, 1ml of freshly prepared solution C and 3ml of DMSO were 
added (Tube 1).                                                                                               
Capsules                                                                                                                
The same procedure was used, using solution B in place of solution A 
(Tube2).                                                                                                      
Mixture                                                                                                                   
To 0.2ml of solution A, 0.2ml of solution B and 0.1ml distilled water were 
added. Then, 1ml of freshly prepared solution C and 3ml of DMSO were 
also added.              
Blank                                                                                                                             
It was prepared similarly but with using 0.5ml water omitting solutions A 
and B.                                                                                                                      
All of these solutions were heated in a boiling water bath for 45 minutes and 
allowed to cool at room temperature. The volume was then completed to 
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 10ml with DMSO and measured against blank. This procedure was repeated 
three times.                                                
3.2.2.3.5. Standard addition method                                                           
Aliquot volumes (0, 0.1, 0.2 and 0.3ml) of solution A were transferred into 
four stoppered glass tubes containing 0.2ml of solution B. Distilled water 
was added to adjust the volume to 0.5ml followed by addition of 1ml freshly 
prepared solution C and 3ml DMSO. These volumes were then completed 
to10ml using DMSO after heating in a boiling water bath for 45 minutes 
(Table3-6).   
Blank was prepared similarly but without using solution A and B. After 
cooling to room temperature, the absorbance was measured at 530 and 
390nm and plotted against the final concentration of solution A in order to 
obtain standard addition method graph. 
Table (3-6): Tranexamic acid aliquot solutions for standard addition method 
Solution 
No 
Solution 
B (ml) 
Solution 
A (ml) 
Water 
(ml) 
Solution 
C (ml) 
DMSO 
(ml) 
DMSO* 
(ml) 
Conc.*2 
(µg/ml) 
1 0.2 0 0.3 1 3 5.5 10 
2 0.2 0.1 0.2 1 3 5.5 15 
3 0.2 0.2 0.1 1 3 5.5 20 
4 0.2 0.3 0 1 3 5.5 25 
Blank 0.0 0 0.5 1 3 5.5 0 
*Second addition of DMSO after heating. *2 Tranexamic acid theoretical concentration 
3.2.2.3.6. Assay of tranexamic acid                                                                     
(Direct standard /sample comparison)                                                                    
Capsules                                                                                                                                  
To 0.2, 0.3&0.4ml of solution B, 0.3, 0.2&0.1ml of distilled water were 
added. 1ml freshly prepared solution C followed by 3ml DMSO were added.                            
Standard                                                                                                                                
To 0.2, 0.3&0.4ml of solution B, 0.3, 0.2&0.1ml of distilled water were 
added. 1ml freshly prepared solution C followed by 3ml DMSO were added.                                    
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 Blank                                                                                                                                        
To 0.5ml of distilled water, 1ml of freshly prepared solution C and 3ml of 
DMSO were added.       
Then, the three solutions were heated in a boiling water bath for 45 minutes 
and allowed to cool at room temperature. The volume was completed to 
10ml with DMSO in all. The absorbance of both the sample and the standard 
were measured at 530nm and 390nm against the blank and the content % 
was calculated. This procedure was repeated three times to obtain three 
readings and the mean was then calculated.   
3.2.2.4. Kinetic study of TA-AA complex reaction                                              
Serial dilutions were made from solution A. 0.2, 0.3, 0.4 and 0.5ml of this 
solution were transferred into stoppered glass tubes and then 0.3, 0.2, 0.1 
and 0.0ml of distilled water were added respectively. Addition of 1ml 
freshly prepared solution C and 3ml of DMSO to each tube were made. 
These solutions were then heated in a boiling water bath (10, 15, 20, 25, 30, 
40, 45 and 50 minutes) and allowed to cool at room temperature. The 
volume was then completed to10ml with DMSO and the absorbance was 
measured.  
Blank was prepared in the same manner but without using solution A. Then 
a graph of absorbance against time of different tranexamic acid 
concentrations was plotted and the kinetic parameters were calculated.                                                                          
Fixed absorption time method                                                                  
0.1, 0.2, 0.3&0.5ml of aqueous standard tranexamic acid solution (12ൈ10-3 
M) were transferred into stoppered glass tubes. A volume of distilled water 
were added to adjust the volume to 1ml. 0.5ml freshly prepared solution of 
ascorbic acid in DMSO (12ൈ10-3 M) and 3ml DMSO were added. Blank was 
prepared similarly but without using tranexamic acid solution.  
These solutions were then heated in a boiling water bath for a time at which 
each concentration of tranexamic acid required to attain a fixed absorption 
value. This time was calculated theoretically for each concentration.                                             
The volumes were then completed to10 ml with DMSO after cooling to 
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 room temperature (Table 3-7) and the absorbance was measured against 
blank at 530nm and 390nm.   
Table (3-7): Tranexamic acid solutions for fixed absorption time measurement 
Solution 
No. 
Standard 
solution 
(ml) 
Water 
(ml) 
Ascorbic
acid (ml) 
DMSO 
(ml) 
DMSO* 
(ml) 
TA.conc. 
( M ) 
TA.conc. 
(µg/ml ) 
1 0.1 0.9 0.5 3 5.5 ͳʹ ൈ10-5 19.2 
2 0.2 0.8 0.5 3 5.5 Ͷʹൈ10-5 38.4 
3 0.3 0.7 0.5 3 5.5 ͸͵ൈ10-5 57.6 
4 0.5 0.5 0.5 3 5.5 ͸Ͳൈ10-5 96 
*Second addition of DMSO is after heating and then cooling. 
3.2.2.5. Comparing TA-AA spectrophotometric method with official 
titrimetric method   
3.2.2.5.1. Assay of tranexamic acid capsule using official titrimetric 
method                                             
A mass of the powdered sample equivalent to 0.05g of tranexamic acid was 
accurately weighed and dissolved in 20ml distilled water. Then was    
shaken for 15minutes and transferred into 250ml conical flask without 
filtration. 10ml of formaldehyde solution was added after neutralization with 
sodium hydroxide using phenolphthalein as indicator (slight pink). Then it 
was mixed and titrated with 0.5N sodium hydroxide. The end point was 
determined by formation of stable slight pink color in presence of 
phenolphthalein as indicator. This procedure was repeated three times and 
the content percent was calculated.   
3.2.2.5.2. Assay of tranexamic acid capsule using TA-AA 
spectrophotometric method  
The same methods mentioned in section 3.2.2.3.6.                                             
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 3.2.2.6. Molar ratio method for determination of the stoichiometry    
(Fixed ascorbic acid concentration&varied tranexamic acid concentrations)                         
0.024g of standard tranexamic acid was dissolved in 25ml water 
(concentration 6ൈ10-3 M). 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8,0.9 and 1ml of 
tranexamic acid standard solution were transferred to ten stoppered glass 
tubes and then 0.9, 0.8, 0.7, 0.6, 0.5, 0.4, 0.3, 0.2, 0.1and 0.0ml of distilled 
water were added respectively. From a fresh solution of ascorbic acid, 
prepared by dissolving 0.0211g in 0.5ml water plus 9.5ml DMSO 
(concentration 12ൈ10-3 M), 0.5ml was added to each tube followed by 
addition of 3ml of DMSO in all.                                                                                                
These solutions were heated in a boiling water bath for 45 minutes and 
allowed to cool at room temperature. After completion the volume to 10ml 
by DMSO, the absorbance of the resulting solutions were measured at 530 
and 390nm against blank (Table 3-8). The blank was prepared in the same 
manner with replacement of standard solution volume by distilled water. The 
molar ratio of the complex was obtained from a plot of tranexamic acid over 
ascorbic acid molar ratio Vs absorbance values.                          
Table (3-8): Tranexamic acid aliquot solutions for molar ratio method 
Solution 
No. 
Standard 
solution 
(ml) 
Water 
(ml) 
Ascorbic 
acid (ml) 
DMSO
(ml) 
DMSO* 
(ml) 
TA Conc. 
( M ) 
Molar 
ratio 
TA/AA 
1 0.1 0.9 0.5 3 5.5 6ൈ10-5 0.1 
2 0.2 0.8 0.5 3 5.5 ͳʹ ൈ10-5 0.2 
3 0.3 0.7 0.5 3 5.5 ͳͺ ൈ10-5 0.3 
4 0.4 0.6 0.5 3 5.5 Ͷʹൈ10-5 0.4 
5 0.5 0.5 0.5 3 5.5 Ͳ͵ൈ10-5 0.5 
6 0.6 0.4 0.5 3 5.5 ͸͵ൈ10-5 0.6 
7 0.7 0.3 0.5 3 5.5 Ͷʹ ൈ10-5 0.7 
8 0.8 0.2 0.5 3 5.5 Ͷͺ ൈ10-5 0.7 
9 0.9 0.1 0.5 3 5.5 ͷͶൈ10-5 0.9 
10 1.0 0.0 0.5 3 5.5 ͸Ͳൈ10-5 1.0 
Blank 0.0 1.0 0.5 3 5.5 0 0.0 
*Second addition of DMSO is after heating and then cooling.                                   
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 3.2.2.7. Confirmation tests for oxidation of ascorbic acid by heating                 
A- Silver nitrate reduction test 
In this test ascorbic acid solution was subjected to the same experimental 
conditions that were used for assay of tranexamic acid (section 3.2.2.3.6).                                                                                                               
One ml of 2% (w/v) solution of ascorbic acid was transferred into two tubes. 
Then, 0.5ml of water followed by 3ml of DMSO was added to each tube. 
One of the two tubes (solution A) was heated in a boiling water bath for 45 
minutes while the other tube (solution B) was kept in dark place also for 
45minutes.                                                                                                                                                                                                                  
Then, 0.5ml of 2.5% (w/v) fresh solution of silver nitrate (0.25g in 10ml 
water) was added to each tube and the resulting color was observed. These 
colors were compared with the color that must be produced in identification 
test [43] of ascorbic acid after addition of silver nitrate solution.  
B- UV spectrum of ascorbic acid 
Ten ml of aqueous ascorbic acid solution (0.002% w/v) was transferred into 
two tubes. One of these tubes (solution A) was heated in a boiling water bath 
for 45minutes while the other (solution B) was kept in a dark place for also 
for 45minutes. The UV spectrophotometer was run in scanning mode from 
200-400nm using above solutions against water as blank. Then the resulting 
spectrum of both was compared with the value of ? max that is used for 
identification [43] of aqueous ascorbic acid solution.  
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 4. RESULTS 
.1. Tranexamic acid-DCQ complex    
4.1.1. Absorption spectrum                              
4.1.1.1. Absorption spectrum of tranexamic acid-DCQ complex                                     
The sample of tranexamic acid (250µg/ml) that was prepared to estimate 
? max of the colored complex formed with 2,6dichloroquinone-4-chlorimide  
(section 3.2.1.1.1) gave two peaks at wavelengths 670nm and 412nm with 
absorbance values 0.759 &0.793respectively (Figure 4-1).  
 
 
 
 
 
Figure (4-1): UV/visible absorption spectrum of tranexamic acid-DCQ complex. 
4.1.1. 2. Absorption spectrum of DCQ in the same experimental 
conditions 
The solution of DCQ (175µg/ml) that was prepared under the same 
experimental conditions used for formation of tranexamic acid –DCQ 
colored complex (section 3.2.1.1.2) showed peak at ? max.278nm with 
absorbance value 3.976 (Figure 4-2). 
 
Figure (4-2): UV/visible absorption spectrum of DCQ in same experimental conditions. 
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 4.1.2. Reaction conditions optimization                                                                  
4.1. 2.1. Effect of heating                                                                                           
Non –heating method                                                                                                
To optimize the reaction time of the colored produced, a sample of 
tranexamic acid was prepared (section 3.2.1.2.1) and the absorbance at 
670nm was recorded at different time intervals (Table 4-1) & (Figure 4-3).   
Table (4-1): Absorbance values of TA-DCQ complex at different time intervals     
 Absorbance 
Time (min.) 45 60 75 
 
90 105 120 135 150 
Conc.(µg/ml) 
50  0.054 0.055 0.056 0.057 0.057 0.058 0.059 0.060 
100  0.057 0.062 0.066 0.069 0.073 0.077 0.081 0.085 
200 0.123 0.130 0.134 0.142 0.148 0.156 0.163 0.170 
250 0.167 0.177 0.186 0.193 0.202 0.211 0.219 0.228 
R (100-250) 0.9971 0.996 0.993 0.996 0.995 0.996 0.996 0.996 
                                              
Figure (4-3): Absorbance-time curve of different tranexamic acid concentrations. 
Heating method                                                                                                                    
Table (4-2): Absorbance values of TA-DCQ complex at different heating time 
Heating time Concentration(µg/ml) R 
 50 100 150 200 250  
3 minutes 0.089 0.215 0.376 0.544 0.732 0.9975 
5 minutes Slight change in absorption value  
Effect of heating                                                                                                    
It was observed that the reaction can occur under both heating and non-
heating conditions, but the reaction rate become very fast with heating in a 
boiling water bath.  
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 It was evident from table (4-1) that the maximum color was developed at 
room temperature after 150 minutes while in heating conditions the 
maximum color was developed after three minutes(table 4-2) over the same 
concentrations range (50-250µg/ml). 
The absorbance intensity also markedly increased with heating, as the 
maximum absorbance of 200µg/ml after heating for three minutes (0.544) is 
approximately three times more as compared with the maximum absorbance 
obtained after 150 minutes waiting at room temperature (0.17) for the same 
tranexamic acid concentration (200µg/ml).   
Effect of increase in heating time                                                                 
Increasing heating time from three to five minutes causes slight increase in 
absorbance value (table 4-2) over working tranexamic acid concentration 
range 50-250µg/ml.   
4.1.2.2.Effect of solvent 
Effect of solvent type 
It was found that when using DMSO as solvent, the absorbance intensity 
become higher without change in ? max and the stability of color also increase 
compared with water (The presence of water is necessary due to insolubility 
of drug in DMSO).                                                                                                                 
Effect of solvent volume (DMSO)                                                                            
It was found that the completion of the volume to 10ml by DMSO from zero 
time then measuring after one hour increase the absorbance intensity 
markedly compared with volume completion after one hour (Figure 4-4).  
                         
Figure (4-4): Effect of DMSO volume on absorbance intensity 
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 4.1.2.3.Effect of coupling reagent concentration                                                                 
In absence of sodium acetate  
It was observed that increasing the DCQ concentration lead to an increase in 
the absorbance value till a maximum absorbance is attained, after that 
approximately no change or slight increase occur with increasing DCQ 
concentration. Figure 4-5 demonstrates the effect of DCQ concentrations on 
absorbance value of 200µg/ml tranexamic acid at neutral media. 
                          
Figure (4-5): Effect of DCQ concentration on absorbance of 200µg/ml tranexamic acid 
This effect was found under the selected experimental working conditions 
which are characterized by neutral media and immediate measurement after 
three minutes heating.   
  In presence of sodium acetate                                                                                                                  
In alkaline media (Na+ acetate, pH 8.5) and measurement after waiting for 
one hour at room temperature, it was observed that increase in DCQ 
concentration sometimes lead to an increase in the absorbance value for a 
given tranexamic acid concentration and decrease the absorbance value for 
another concentration of tranexamic acid  after a fixed time measurement. 
Figure 4-6 shows the increase in absorbance value of 15µg/ml tranexamic 
acid upon DCQ concentration increase from 0.5% to 0.8% at alkaline media.  
                        
Figure (4-6): Effect of DCQ concentration on absorbance of 15µg/ml tranexamic acid 
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 Figure 4-7 shows the decrease in absorbance value of 3µg/ml tranexamic 
acid upon DCQ concentration increase from 0.5% to 0.8% at alkaline media 
(pH 8.5).  
                          
Figure (4-7): Effect of DCQ concentration on absorbance of 3µg/ml tranexamic acid 
4.1.2.4. Effect of alkaline media 
It was found that the increase in Na+ acetate concentration cause increase in 
the reaction rate and the formed complex reach maximum absorbance very 
fast. Then, this absorbance decrease rapidly causing sharp peak. This 
sharpness decreases with decrease in drug concentrations (Figure 4-8).   
                           
Figure (4-8): Effect of Na+ acetate on color stability of different TA concentrations 
This sharp peak becomes wider with decrease in the acetate concentration 
even with higher tranexamic acid concentrations but the absorbance intensity 
decrease largely (Figure 4-9).   
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Figure (4-9): Effect of Na+ acetate concentrations on color stability 
In neutral media, the peak became approximately linear but the absorbance 
intensity markedly reduced with slight change in ? max (from 680 to 674nm).    
                               
 
4.1.2.5. Color stability of tranexamic acid-DCQ complex                                       
Color stability was estimated by measuring the absorbance of 200µg/ml 
tranexamic acid sample at 670nm at different time intervals after heating for 
3minutes (section 3.2.1.2.5). The results were shown in table (4-3) & figure 
(4-11).                                                                                                                       
Table (4-3): Absorbance values for color stability estimation 
Figure (4-11): Color stability estimation curve                                             
Ϭ
ϭ
Ϯ
ϯ
ϰ
Ϭ ϱϬ ϭϬϬ ϭϱϬ ϮϬϬAbsorance Time(minutes) ͸Ͳug/ml.  ͳͲ% acetate.ͳʹͲug/ml. ͳ% acetate.ϬϬ.ϱϭϭ.ϱϮϮ.ϱϯϯ.ϱ Ϭ ϮϬ ϰϬ ϲϬ ϴϬ ϭϬϬ ϭϮϬsrace Time(minutes) ͸Ͳug/ml.ͳͲ%acetate.͹ͷug/ml. neutralϬ%ϮϬ%ϰϬ%ϲϬ%ϴϬ%ϭϬϬ% ϯϬ ϲϬ ϳϱ ϵϬTime (min.) Absorbance 10 0.557 15 0.557 30 0.563 45 0.565 75 0.576 90 0.577 Figure (4-10): Effect of alkaline & neutral media on color stability Time (min.) Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 4.1. 3. Validation of the proposed method 
4.1.3.1. Construction of calibration curve [25]                                                     
The absorbance values  at ? max 670nm (Table 4-4)  that were obtained by 
procedure mentioned in section (3.2.1.3.1) were plotted against the final 
tranexamic acid concentrations in order to obtain the calibration graphs 
(Figure 4-12) .Then the mean absorbance values of the four replicates were 
calculated to construct average calibration curve. 
Table (4-4): Absorbance values of standard tranexamic acid solutions 
 1 2 3 4 5 
Concentration. (M) 3.125×10-3 6.25×10-3 9.375×10-3 12.5×10-3 15.625×10-3 
Concentration.(% w/v) 0.005 0.01 0.015 0.02 0.025 
Concentration.(µg/ml) 50 100 150 200 250 
Abs.Sample1 at 
? max670 
0.095 0.202 0.367 0.577 0.759 
Abs.Sample2 at 
? max670 
0.091 0.202 0.381 0.566 0.757 
Abs.Sample3 at 
? max670 
0.096 0.209 0.361 0.558 0.713 
Abs.Sample4 at 
? max670 
0.089 0.215 0.376 0.544 0.732 
Mean       0.09275 0.207 0.37125 0.56125 0.7402 
SD 0.003304 0.006272 0.008958 0.013889 0.02193 
 
In order to evaluate the results, statistical analysis was done for each curve. 
The regressions(R), slopes (B) and intercepts (A) values of the five curves 
were shown in the following table. 
       Table (4-5): R, A & B values for the calibration curves 
Curve No. R A B 
Curve1 0.9940 -0.1109 3.406×10-3 
Curve2 0.9958 -0.1094 3.392×10-3 
Curve3 0.9960 -0.0875 3.166×10-3 
Curve4 0.9975 -0.0933 3.230×10-3 
Curve(mean) 0.9961 -0.100275 3.299×10-3 
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The average equation that can be used for calculation of tranexamic acid 
concentration is Y= -0.1+ 3.3×10-3 X. Where, Y is the absorbance of 
tranexamic acid and X is the concentration of tranexamic acid.                                                                                   
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Figure (4-12): Standard tranexamic acid calibration curves. 
Statistics of average calibration curve [44]                                                                                         
Error of the slope and the intercept    
X X2 X` (X-X`)2 y y  (y- y )2 
50 2 500 150 10 000 0.09275 0.06465 7.8961×10-4 
100 10 000 150 2 500 0.207 0.229575 5.0963×10-4 
150 22 500 150 0 0.37125 0.3945 5.4056×10-4 
200 40 000 150 2 500 0.56125 0.559425 3.3306×10-6 
250 62 500 150 10 000 0.74025 0.72435 2.5281×10-4 
෍   137500  25 000   2.0959×10-3 
To estimate the random errors in the y-direction (Sy/x).                                  
Sy/xൌඥσሺݕെþሻ ଶȀሺ݊െ ሻʹൌඥʹ ǤͲͻͷͻൈͳͲିଷȀ͵ ൌ 0.0264.              
Ϭ
Ϭ.ϭ
Ϭ.Ϯ
Ϭ.ϯ
Ϭ.ϰ
Ϭ.ϱ
Ϭ.ϲ
Ϭ.ϳ
Ϭ.ϴ
Ϭ ϭϬϬ ϮϬϬ ϯϬϬAbsorance ConcentrationCalibration curve ͵ ϬϬ.ϭϬ.ϮϬ.ϯϬ.ϰϬ.ϱϬ.ϲϬ.ϳϬ.ϴ Ϭ ϭϬϬ ϮϬϬ ϯϬϬAbsorance Concentration Calibration curve ͶϬϬ.ϭϬ.ϮϬ.ϯϬ.ϰϬ.ϱϬ.ϲϬ.ϳϬ.ϴϬ ϱϬ ϭϬϬ ϭϱϬ ϮϬϬ ϮϱϬ ϯϬϬsrace (m) Concentration(mean)Average calibration curve  Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 Standard deviation of the slope (Sb).                                                                           
Sb ൌ
 ୗ౯Ȁ౮
ඥσሺ௫ି ௫ҧሻమ 
ൌ  ଴Ǥ଴ଶ଺ସ
ξଶହ଴଴଴
ൌ1.6697×10-4.                                                       
Standard deviation of the intercept ( Sa).                                                                                                                                              
Sa  = Sy/x ඥσݔଶ Ȁ݊σሺݔെݔҧሻଶ = 0.0264ඥͳ͵͹ͷͲͲȀͷൈ ͷʹͲͲͲ = 0.0277.     
t-value for (n-2) =3 degrees of freedom &95% confidence level is 3.18.                                                                                                                   
The 95% confidence limits for the slope of the line (b ± t(n-2) Sb).                     
3.2985×10-3± (3.18×1.6697×10-4) = 3.2985×10-3±5.3×10-4 .                                                  
The 95% confidence limits for the intercept of the line (a ± t(n-2) Sa).                                       
-0.100275± (3.18×0.0277) = -0.100275±0.0881.                                                               
Limit of detection (LOD).                                                                                                   
The value of y at the limit of detection is Y=Yb+3Sb. (i.e.  Yb=a, Sb=Sy/x ).                           
-0.100275+3×(0.0264) = -0.021075.                                                                             
The limit of detection is X=y-a/b.                                                                                                                         
- 0.021075 +0.100275/3.2985×10-3 = 24.01µg/ml.                                             
Limit of quantification (LOQ).                                                                                            
The value of y at the limit of quantification isY=Yb+10Sb.(i.e.Yb=a, Sb=Sy/x )                 
-0.10028+10×(0.0264) = 0.163725.                                                                                         
The limit of quantification is X=y-a/b.                                                                                                                         
0.163725+0.100275/3.2985×10-3 = 80.04µg/ml.                                                  
Molar absorbtivityሺߝሻ[26].                                                                                                  
The concentration of molar solution is 157.2×103µg/ml.                                     
At ? max670nm, ? =0.100275+0.0032985(157.2×103) =518.42mol-1cm-1.                                                                                                  
4.1.3.2. Construction of sample curve 
The absorbance values of sample solutions were measured at the range of 
600nm-800nm against their blank (Table 4-6). These values were plotted 
against the final tranexamic acid concentrations in order to obtain a 
calibration graphs (Figure 4-13).  
This procedure (section3.2.1.3.2) was carried out four times and the mean 
absorbance values were calculated to construct a final calibration curve. 
Table (4-6): Absorbance values of sample tranexamic acid solutions 
 1 2 3 4 5 
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 Conc. M 3.125×10-3 6.25×10-3 9.375×10-3 12.5×10-3 15.625×10-3 
Conc.(%w/v) 0.005 0.01 0.015 0.02 0.025 
Conc.(µ/ml) 50 100 150 200 250 
Abs.Sample1 0.0 0. 0.3 0.5 0.7 
Abs.Sample2 0.0  0.2 0.3 0.5 0.77 
Abs.Sample3 0.09 0.209 0.3 0.55 0.71 
Abs.Sample4 0.0 0.2 0.37 0.5 0.7 
Mean 0.08975 0.21325 0.36775 0.54125 0.71975 
SD 0.045551 0.011846 0.009605 0.025131 0.014863 
 
In order to evaluate the results, statistic analysis was done for each curve.  
The regressions (R), slopes (B) and intercepts (A) values of the five curves   
are shown in table (4-7) below.     
     Table (4-7): R, A & B values for the sample curves 
Curve No. R A B 
Curve1 0.9954 -0.1002 3.204×10-3 
Curve2 0.9966 -0.0816 3.056×10-3 
Curve3 0.9983 -0.0872 3.184×10-3 
Curve4 0.9970 -0.0912 3.26×10-3 
Curve(Average) 0.9975 -0.09005 3.176×10-3 
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Figure (4-13): Tranexamic acid sample curves. 
 
4.1.3.3. Repeatability and reproducibility of the method [26]                                                   
In order to evaluate reproducibility and repeatability, one concentration of 
tranexamic acid solution (150µg/ml for reproducibility and 200µg/ml for 
repeatability) was assessed (section3.2.1.3.3).The recovery % was calculated 
in tables below as the following: A /Aaverage×100.  A: the absorbance value.   
Table (4-8): Standard tranexamic acid solutions absorption values in different days 
 Conc. Day(1) Day(2) Day(3) Mean SD 
Abs. 150 0.367 0.361 0.376 0.368 0.00755 
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 % 150 99.73% 98.10% 102.17% 100 2.04839 
The mean recovery is 100± 2.05 %.                                                                 
Table (4-9): Tranexamic acid capsules solutions absorption values in different days                                                       
 Conc.  Day(1) Day(2) Day(3) Mean SD 
Abs.  150  0.369 0.376 0.372 0.3723  0.003512  
% 150  99.11  100.99  99.92  100.01  0.94  
The mean recovery is 100.01± 0.94 %.                                                                  
Table (4-10): Standard tranexamic acid solutions absorption values on the same day                                                           
 Conc. Sample(1) Sample(2) Sample(3) Mean SD 
Abs. 200 0.577 0.566 0.558 0.567  0.009539  
% 200  101.76  99.82 98.41  99.99  1.68    
The mean recovery is 99.99± 1.68 %.                                                            
Table (4-11): Tranexamic acid capsules solutions absorption values on the same day                                                          
 Conc.  Sample(1) Sample(2) Sample(3) Mean SD 
Abs. 200  0.550 0.552  0.559 0.5537  0.004726 
% 200    99.33 99.69  100.96  99.99  0.86  
The mean recovery is 99.99± 0.86 %.                                                              
4.1.3.4. Added recovery (%) by the DCQ method                                    
To determine the added recovery (%) by the proposed method 100µg/ml of 
standard tranexamic acid, 100µg/ml of tranexamic acid capsules & a mixture 
of both were used (section 3.2.1.3.4). The recovery percent was calculated     
according to the following formula: Recovery(%) = (Astandard(1)/Astandard)×100. 
Where Astandard(1)= Amixture -Asample (Table 4-12).                                                                                                     
    Table (4-12): Added recovery (%) using the proposed method   
Sample    
No. 
Abs.of 
mixtur 
Abs.of 
sample 
Abs.of 
standard(1) 
Abs.of 
standard 
Recovery 
(%) 
1 0.587 0.210 0.377 0.220 171.36% 
2 0.567 0.206 0.361 0.208 173.56% 
3 0.581 0.218 0.362 0.221 163.80% 
    Recovery percent is 169.57 ±5.12%.                                                                                                                                             
      Using first standard curve equation (Y= -0.1109 + 3.406×10-3X) 
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 Sample 
No. 
Abs. of  
mixture  
Conc.of mix.  
(calculated) 
Conc.of  mix.  
(theoretical) 
Recovery 
(%) 
1 0.587 204.90  200 102.45%   
2 0.567 199.03   200 99.52%  
3 0.581 203.14 200 101.57% 
    Using second standard curve equation (Y=-0.1094 + 3.392×10-3X) 
Sample 
No. 
Abs. of 
mixture 
Conc.of mix. 
(calculated) 
Conc. of mix. 
(theoretical) 
Recovery 
(%) 
1 0.587 205.31 200 102.65% 
2 0.567 199.41 200 99.71% 
3 0.581 203.54 200 101.76% 
    Recovery percent is 101.28 ± 1.35%. 
4.1.3.5. Standard addition method [25]                                                          
Standard addition method samples were prepared by adding aliquot volumes 
(0, 0.5, 1&1.5ml) of standard tranexamic acid to a fixed tranexamic acid 
sample solutions containing100µg/ml (section 3.2.1.3.5). The absorbance 
values were recorded in table (4-13). A graph was drawn to evaluate the 
possible interference that may occur (Figure 4-14).                                                                              
Table (4-13): Standard addition method results 
Sample No. Capsule conc. (µg/ml) Standard conc. (µg/ml) Abs. 
1 100 0 0.235 
2 100 50 0.425 
3 100 100 0.615 
4 100 150 0.794 
 
                                              
Figure (4-14): Standard addition method curve.                                                        
R=0.999895, A= 0.2372, B=3.734×10-3. 
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 Concentration of tranexamic acid in the sample                                                                                                                                            
The regression equation is Abs= 0.2372 +3.734×10-3 C. (R =0.999895).     
The concentration was calculated from the extraplotted x-value when y=0. 
XE=(Y-A)/B =0- 0.2372/3.734×10-3 = - 63.52 µg/ml.                                          
Recovery %                                                                                                   
The recovery percent is (Xaxis contribution/ sample stated amount) ×100.                                                       
63.52/100×100= 63.52%.                                                                                                             
Confidence limit [44]                                                                                                    
The random error in the y-direction (Sy/x).                                                                                                                             
Sy/xൌඥσሺݕെþሻ ଶȀሺ݊െ ሻʹ  ൌඥ͵ Ǥ͸͵ ൈͳͲିହȀʹ  ൌ 4.26×10-3.                        
The standard deviation of extra plotted x-value (SXE).                                                   
SXE = 
ୗ୷Ȁ୶  
ୠ
  ටଵ௡൅
 ଶ
ୠଶσሺ௫ି ௫ҧሻమ 
 = ସǤଶ଺ൈଵ଴ି ଷ
ଷǤ଻ଷସൈଵ଴ି ଷ
  ටଵସ൅
ሺ଴Ǥହଵ଻ଶହሻଶ
ሺ ଷǤ଻ଷସൈ ଵ଴షయሻ మǤଵଶହ଴଴
 =1.523.                                                                                           
The t-value for (n-2)=2 degrees of freedom and 95%confidence level is 4.3.                                                                               
The 95% confidence limit for this concentration (XE ± t(n-2)SXE).                                                 
63.52 ± (4.3×1.523) = 63.52 ± 6.55 µg/ml.                                                                              
Concentration of tranexamic acid in sample using calibration curve 
equations                                                                                                                         
Abs= -0.1109 +3.406×10-3 C.                                                                            
The concentration is 0.235+0.1109/3.406×10-3 = 101.56 µg/ml.                   
Abs= -0.0875+3.166×10-3 C.                                                                               
The concentration is 0.235+0.0875/3.166×10-3 = 101.86µg/ml.                 
Abs= -0.1003 +3.299×10-3 C.                                                                              
The concentration is 0.235+0.1003/3.299×10-3 = 101.64 µg/ml.                                                                                                                                                                      
The recovery percent is101.65/100×100 = 101.69± 0.16% . 
4.1.3.6. Assay of tranexamic acid capsules by the proposed method  
Direct standard/sample comparison method                                
The direct standard/sample comparison method was used to assay 
tranexamic acid capsules by the developed method. The assay was carried 
out in three concentrations 100, 150 & 250µg/ml and the procedure was 
repeated three times (section 3.2.1.3.6).  
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 The following formula was adopted to calculate the content of tranexamic 
acid (Tables 4-14, 4-15 & 4-16) in capsules as percent (%w/w) considering 
equal sample and standard concentrations. Asample/Astandard×100.                                                                                                    
Asample: absorbance of the sample, Astandard: absorbance of the standard.                                                                                               
Table (4-14): Content percent statistics for capsule (100µg/ml) 
 Conc.(µg/ml) Abs.1 Abs.2 Abs.3  
Standard 100 0.215 0.209 0.202 
Sample 100 0.218 0.209 0.196 Mean±SD 
Content %  101.40% 100% 97.03% 99.48±2.23% 
Table (4-15): Content percent statistics for capsule (150µg/ml) 
 Conc.(µg/ml) Abs.1 Abs.2 Abs.3  
Standard 150 0. 367 0.381 0.361 
Sample 150 0.369 0.376 0.372 Mean±SD 
Content %  100.54% 98.69% 103.05% 100.76±2.2 % 
Table (4-16): Content percent statistics for capsule (250µg/ml)     
 Conc.(µg/ml) Abs.1 Abs.2 Abs.3  
Standard 250 0.713 0.713 0.732 
Sample 250 0.713 0.707 0.741 Mean±SD 
Content %  100 % 99.16% 101.23% 101.13±1.04 % 
Table (4-17): Mean content percent of the three concentrations 
Mean content percent Mean SD 
100 µg/ml 150 µg/ml 250µg/ml   
99.48% 100.76% 100.13% 100.12% 0.640026 
 
The content percent of (TREXAMINE®) capsules is 100.12±0.64%.                    
Slope method                                                                                                           
The following formula was adopted also to calculate the content percent 
(%w/w) of tranexamic acid in capsules (Table 4-18) directly from the sample 
and standard curves. Content % =Slopesample curve/slopestandard curve. ×100. 
Slope Curve1 Curve2 curve3 
Standard 3.23×10-3 3.166×10-3 3.198×10-3 
Table (4-18): Content percent using slope method    
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 The content percent of (TREXAMINE®) capsules is 100.56±0.9%.               
4.1.4. Kinetics of tranexamic acid–DCQ complex reaction                              
The absorbance values of 50, 100, 200, and 250µg/ml of tranexamic acid 
after treating with DCQ in presence of DMSO at different time intervals 
(section 3.2.1.4) were recorded in table 4-19 & figure 4-15 below.                                                        
Table (4-19): TA-DCQ complex absorbance values at different time intervals 
Conc.(µg/ml) 50 100 200 250 
Time (min.) Absorbance 
45 0.054 0.057 0.123 0.167 
60 0.055 0.062 0.130 0.177 
75 0.056 0.066 0.134 0.186 
90 0.057 0.069 0.142 0.193 
105 0.057 0.073 0.148 0.202 
120 0.058 0.077 0.156 0.211 
135 0.059 0.081 0.163 0.219 
150 0.060 0.085 0.170 0.228 
                                               
Figure (4-15): Absorbance-time curve of different tranexamic acid concentrations. 
Initial rate method [45]                                                                                            
The initial rate (Table 4-20) of the reaction was determined from the 
measurement of the slope (? A/? t) of the initial tangent to the absorbance-
time curve for different concentrations of tranexamic acid.  
The initial rate of reaction would obey the following equation:                                  
r =? A/? t=KCn. Whereas r is the reaction rate, A is the absorbance, t is the 
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 measuring time, K is the rate constant, C is the concentration of tranexamic 
acid and n is the order of the reaction. The logarithmic form of this equation 
is: log r = log ? A/? t = log K’+ n logC.                                                                             
A calibration curve was constructed by plotting log rate versus log C (Figure 
4-16) which showed a linear relationship over the concentration range of 
100-250µg/ml (6.36×10-4-1.59×10-3M).   
           Table (4-20): Results for initial rate curve   
Concentration 
(M) 
Initial rate 
(Ms-1 ) 
Log 
concentration 
Log 
Initial rate 
3.18×10-4 6.67×10-5 -3.50 -4.18 
6.36×10-4 2.44×10-4 -3.20 -3.61 
1.27×10-3 4.67×10-4 -2.90 -3.33 
1.59×10-3 5.56×10-4 -2.80 -3.26 
                        
Figure (4-16): Initial rate curve.                                                                                     
The regression equation and related data were presented in table below.                      
log r = -0.76+0.89log C    ………………………….(1) 
Parameter  
Linear dynamic range(µg/ml) 100 -  250 
Intercept (a± tSa) -0.76 ± (0.138) 
 Slope (b± tSb) 0.89 ± (0.047) 
Correlation coefficient(R)     0.998 
Reaction order [45]    
Reaction order with respect to tranexamic acid was evaluated from the n 
value (0.89) of the plot of log r versus log C.                                                                                 
Reaction order with respect to tranexamic acid was also ascertained by 
studying the reaction at different concentrations of tranexamic acid keeping 
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 constant concentration of DCQ. For each run a plot of A8 /A8 - At versus 
time, log A8 /A8 - At versus time were constructed (Figure 4-17,18,19,20).                                                                                                                                   
Table (4-21): Reaction order estimation using 50µg/ml tranexamic acid 
Time(min.) Absorbance A8 /A8 - At Log A8 /A8 - At 
45 0.054 10 1 
60 0.055 12 1.08 
75 0.056 15 1.18 
90 0.057 20 1.30 
105 0.057 20 1.30 
120 0.058 30 1.48 
135 0.059 60 1.78 
 R 0.85  0.95   
A  -16.43 0.605  
B 0.455  7.76 ×10-3 
 
 
Figure (4-17): Reaction order curve of 50µg/ml tranexamic acid 
 
 
Table (4-22): Reaction order estimation using 100µg/ml tranexamic acid 
Time (min.) Absorbance. A8 /A8 - At Log A8 /A8 - At 
45 0.057 3.04 0.48 
60 0.062 3.70 0.57 
75 0.066 4.47 0.65 
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 90 0.069 5.31 0.73 
105 0.073 7.08 0.85 
120 0.077 10.63 1.03 
135 0.081 21.25 1.33 
 
 
R  0.85 0.96  
A  -7.31 0.019 
B  0.169 8.74×10-3   
 
 
Figure (4-18): Reaction order curve of 100µg/ml tranexamic acid. 
Table (4-23): Reaction order estimation using 200µg/ml tranexamic acid 
Time (min.) Absorbance. A8 /A8 - At Log A8 /A8 - At 
45 0.123 3.62 0.56 
60 0.130 4.25 0.63 
75 0.134 4.72 0.67 
90 0.142 6.07 0.78 
105 0.148 7.73 0.89 
120 0.156 12.14 1.08 
135 0.163 24.29 1.39 
 
 
 
R  0.84 0.95  
A  -8.34 0.083  
B  0.192 8.60×10-3  
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 Figure (4-19): Reaction order curve of 200µg/ml tranexamic acid.                                               
Table (4-24): Reaction order estimation using 250µg/ml tranexamic acid 
Time (min.) Absorbance A8 /A8 - At Log A8 /A8 - At 
45 0.167 3.74 0.57 
60 0.177 4.47 0.65 
75 0.186 5.43 0.73 
90 0.193 6.51 0.81 
105 0.202 8.77 0.94 
120 0.211 13.41 1.13 
135 0.219 25.33 1.40 
 R 0.86   0.96 
A  -8.76  0.105 
B 0.205   8.71×10-3 
Figure (4-20): Reaction order curve of 250µg/ml tranexamic acid. 
Rate constant method [45]                                                                                    
The first order rate constants (k) corresponding to different concentrations of 
tranexamic acid were evaluated from the slopes of the plots of log 
(A8 /A8 - At) versus time which are summarized in table below.                                                                                             
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 Table (4-25): Rate constants of different tranexamic acid concentrations 
Concentration(M) 
 
Rate constant(s-1) Intercept  Correlation coefficient 
       3.18×10-4 7.76×10-3   0.605 0.95   
6.36×10-4  8.74×10-3    0.019 0.96 
1.27×10-3 8.60×10-3  0.083 0.95  
1.59×10-3  8.71×10-3  0.105 0.96  
Calibration graph (Figure 4-21) that was constructed by plotting rate 
constants (k) against initial tranexamic acid concentrations does not show 
linear response over the concentration range of 50-250µg/ml (3.18×10-4 -
1.59×10-3M).              
                                         
Figure (4-21): Rate constant curve. 
Fixed time method [45]                                                                                                
At preselected fixed time, the absorbance values of different tranexamic acid 
concentrations were measured at 670nm and the results were shown in table 
above (table4-19). The regression of absorbance versus initial tranexamic 
acid concentrations at fixed time starting from 45 to 150 minutes were 
summarized in table (4-26) over the concentration range 100- 250µg/ml.                                             
                  Table (4-26): Fixed time method results                                                                                                                             
Time (min.) R A B 
45 0.997 -0.0169 7.2 ×10-4 
60 0.996 -0.0153 7.5×10-4 
75 0.993 -0.0149 7.8×10-4 
90 0.996 -0.0144 8.1×10-4 
105 0.995 -0.0138 8.4×10-4 
120 0.996 -0.0131 8.8×10-4 
135 0.996 -0.0117 9.06×10-4 
150 0.996 -0.0111 9.39×10-4 
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 The regression equation and important analytical parameters at a fixed time 
of 45 minutes were summarized in table below.                                            
Absorbance at 45min. = -0.0169 + 7.2×10-4 C………..…... (2) 
Linear dynamic range(µg/ml)   100 -  250 
Intercept (a± tSa)   -0.0169 ± (12.71×0.0107) 
 Slope (b± tSb)   7.2×10-4± (12.71×5.53×10-5) 
Correlation coefficient(R)       0.997 
Limit of detection (µg/ml)    24.88 
Molar absorbtivity(ߝሻ   113.1671                             
 
Fixed absorption time method [45]   
In a fixed absorption time method (section 3.2.1.4), the absorbance value 
0.074 was fixed and the time at which each concentration of tranexamic acid 
can take to attain this value was determined (Table 4-27). 
Table (4-27): Results for fixed absorption time method   
Concentration(µg/ml) 100 150 200 250 
Time (minutes) to 
attain  absorbance 
equal to 0.074 
90 23 Zero time Zero time 
absorbance obtained 0.074 0.074 Higher than 
0.074(0.093) 
Higher than 
0.074(0.112) 
                                                                                                                             
4.1.5. Comparing TA-DCQ spectrophotometric method with official 
titrimetric method [44]  
Assay of tranexamic acid capsules usingofficial titrimetric method[7].                                                                                                                      
The capsules content percent (Table 4-28) was calculated according to the 
following formula:                                                                                                                  
Content% = titer value ×volume of titrant×100/ weight of titrand.                                             
Titer value=Mwt of titrand (drug) ×molar conc.of titrant (NaoH)/1000.                                                                                         
Titer value= 157.2×0.5/1000=0.0786.                                                                      
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 The volumes of sodium hydroxide result from three independent analyses 
(section 3.2.1.5.1) were 6.5, 6.3 and 6.4ml.                                                                                              
Stated amount of tranexamic acid in two capsules is 500mg.                                   
Table (4-28): Content percent of tranexamic acid capsules using titration 
Sample No. Volume of NaoH Content % SD 
1 6.5 102.18  
2 6.3 99.036  
3 6.4 100.608  
mean  100.608 1.572 
The content percent of (TREXAMINE)® is 100.61±1.6%. 
Assay of tranexamic acid capsule using TA-DCQ spectrophotometric 
method  
The content percent of TREXAMINE® capsules according to the proposed 
method is100.12±0.64%. This value is mean of three independent analyses 
of three concentrations (100,150 &250µg/ml) of tranexamic acid 
(section4.1.3.6). 
t-test                                                                                                                        
To evaluate the accuracy of the proposed method comparing with titrimetric 
method, t-test was made.                                                                                                                              
Calculated t-value                                                                                               
(X`1-X`2)/ට ܵܦଵଶ ଵ݊ൗ ൅ ܵܦଶ
ଶ
ଶ݊
ൗ = (100.12-100.61)/ ටͲǤ͸Ͷଶൗ͵ ൅ͳǤ͸ଶൗ͵ = - 0.493.                                                 
Tabulated t-value                                                                                               
The number of degrees of freedom is ሺௌ஽భ
మ
௡భ
൅ௌ஽మ
మ
௡భ
ሻ ଶ ሺ ௌ஽భ
ర
௡భమሺ௡భି ଵሻ
൅ ௌ஽మ
ర
 ௡మమሺ௡మି ଵሻ
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Where, X`:mean content percent, SD: standard deviation, n: number of 
measurements. ሺ଴Ǥ଺ସ 
మ
ଷ
൅ଵǤ଺ 
మ
ଷ
ሻ ଶ ሺ଴Ǥ଺ସ 
ర
 ଷ  మሺଷି ଵሻ
൅ ଵǤ଺
ర
 ଷమሺଷି ଵሻ
ሻൗ =2.6 ؆ 3.                                                                                                         
At 95%confidence level &3degrees of freedom, the tabulated t-value is 3.18.                                                                                                  
F-test                                                                                                                    
To evaluate the precision of the proposed method comparing with titrimetric 
method, F-test was made.                                                                     
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 Calculated F-value                                                                                         
ܵܦଵଶ ܵܦଶଶΤ  =ͳǤ͸ଶͲǤ͸ͶଶΤ =6.25.                                                                             
Tabulated F-value                                                                                             
The numbers of degrees of freedom are n1-1 and n2-1 = 2 & 2 respectively. 
At95% confidence level&F2,2 degrees of freedom,the tabulated F-value is 19.     
4.1.6. Stoichiometry of the reaction using molar ratio method[31]                                                                                                                              
(Fixed DCQ concentration against different tranexamic acid concentrations)  
The results obtained from the study of the reaction stoichiometry between 
tranexamic acid and DCQ (section 3.2.1.6) were shown in table 4-29 and 
figure 4-22. The molar ratio between tranexamic acid and DCQ was found 
2:1 respectively.                                                                                                        
    Table (4-29): Molar ratio method (fixed DCQ concentration) results  
Conc.of TA (M) Vol.of TA (ml) Molar ratioTA / DCQ Abs. 
1.2×10-3 0.50 1 0.509 
1.8×10-3 0.75 1.5 0.979 
2.4×10-3 1.00 2 1.961 
3×10-3 1.25 2.5 1.832 
3.6×10-3 1.50 3 1.819 
4.2×10-3 1.75 3.5 1.816 
4.8×10-3 2.00 4 1.623 
                            
                       
Figure (4-22): Molar ratio curve of TA/DCQ. 
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 .2. Tranexamic acid–ascorbic acid complex 
4.2.1. Absorption spectrum                             
 4.2.1.1. Absorption spectrum of tranexamic acid-ascorbic acid complex 
The sample of tranexamic acid (25µg/ml) that was prepared to estimate ? max 
of the colored complex formed with ascorbic acid(section 3.2.2.1.1)gave 
two peaks at wavelengths 390nm and 530nm with absorbance values 0.101 
& 0.330 respectively (Figure 4-23). 
 
           Figure (4-23): UV/visible absorption spectrum of TA-AA complex. 
4.2.1.2. Absorption spectrum of ascorbic acid in the same conditions 
The solution of ascorbic acid (2×103µg/ml) that was prepared under the 
same experimental conditions used for formation of tranexamic acid-
ascorbic acid colored complex (section 3.2.2.1.2) showed two peaks at 
? max.272& 304nm with absorbance values 3.836 and 0.870 respectively 
(Figure 4-24).  
 
Figure (4-24): UV/visible absorption spectrum of AA in same experimental conditions. 
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 4.2.2. Reaction conditions optimization                                                                 
4.2.2.1. Effect of heating 
To optimize the reaction time of the colored product, samples of tranexamic 
acid were prepared (section 3.2.2.2.1) and the absorbance values at 
530&390nm were recorded at different heating time intervals (Table 4-30 & 
Figure 4-25).                                                                                                                
Table (4-30): Absorbance values of TA-AA complex at different time intervals   
Time ?  Concentration   (µg/ml) R 
   10 15 20 25  
  Absorbance.  
10 390 0.014 0.024 0.036 0.029 0.795 
530 0.003 0.005 0.006 0.005 0.718 
15 390 0.037 0.050 0.081 0.083 0.954 
530 0.010 0.012 0.021 0.020 0.905 
20 390 0.055 0.100 0.145 0.171 0.993 
530 0.016 0.028 0.039 0.048 0.9979 
25 390 0.061 0.110 0.177 0.182 0.9591 
530 0.015 0.029 0.052 0.053 0.9551 
30 390 0.058 0.137 0.199 0.253 0.99946 
530 0.027 0.043 0.063 0.079 0.99896 
40 390 0.096 0.178 0.223 0.282 0.9928 
530 0.022 0.048 0.079 0.089 0.9823 
45 390 0.113 0.200 0.267 0.336 0.9980 
530 0.034 0.062 0.085 0.107 0.9983 
              
Figure (4-25): Absorbance-time curve of different tranexamic acid concentrations. 
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 It was observed that the color does not develop at room temperature but only 
after heating in a boiling water bath. The absorbance intensity increased with 
increasing heating time and the maximum color developed after 45minutes 
over the linear concentration range (10-25µg/ml).  
4.2.2.2. Effect of solvent  
Effect of solvent type 
It was found that using water instead of DMSO as solvent give very low 
absorbance value after two long heating time. The absorbance intensity in 
the solvent mixture of DMSO and water increased, when the ratio of DMSO 
over water increased.   
Effect of solvent volume (DMSO)                                                                                         
It was also observed that the high content of DMSO before heating increased 
the absorbance intensity and reaction rate compared with the low content 
before heating. Both have the same final volume and heating time (Figure  
4-26 & 4-27).  
                            
Figure (4-26): Effect of DMSO concentrations on absorbance at390nm  
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 4.2.2.3. Effect of ascorbic acid in different solvents      
 Ethanol and isopropanol                                                                             
It was observed that the solution of ascorbic acid in isopropanol shows high 
increase in absorbance intensity of tranexamic acid than solution of ascorbic 
acid in ethanol and this difference in reading increase with increasing drug 
concentration (Figure 4-28 & 4-29).     
                               
Figure (4-28): Effect of ethanol, isopropanol on absorbance at 390nm 
                          
Figure (4-29): Effect of ethanol, isopropanol on absorbance at 530nm 
Isopropanol and DMSO 
The solution of ascorbic acid in DMSO shows slight increase in absorbance 
intensity of tranexamic acid compared with ascorbic acid in isopropanol. 
This effect starts to increase with increasing drug concentration, then after 
certain drug concentration it starts to decrease (Figure 4-30 & 4-31).     
The difference in absorbance intensity that was given by ethanol-isopropanol 
is relatively greater than that was given by isopropanol-DMSO.                         
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Figure (4-30): Effect of isopropanol, DMSO on absorbance at390nm 
                     
Figure (4-31): Effect of isopropanol, DMSO on absorbance at 530nm 
4.2.2.4. Effect of mixing order  
It was observed that the addition of coupling reagent (ascorbic acid) to the 
aqueous drug solution before DMSO increases the absorbance intensity 
compared with addition of  DMSO first (Figure 4-32 & 4-33).  
                               
Figure (4-32): Effect of mixing order on absorbance at 390nm 
                            
Figure (4-33): Effect of mixing order on absorbance at 530nm 
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 4.2.2.5. Effect of ascorbic acid concentration                                                                  
It was observed that the absorbance intensity increases with increase  in 
ascorbic acid concentration for a given tranexamic acid  concentration in the 
linear range (10-25µg/ml) till reach maximum absorbance after which any 
increase in ascorbic acid cause slight or no change in absorbance value 
(Figure 4-34).   
                         
Figure (4-34): Effect of ascorbic acid concentrations (1%? 3%) on absorbance                        
of 25µg/ml of tranexamic acid 
4.2.2.6. Color stability of tranexamic acid-ascorbic acid complex                                     
The results obtained from measuring the absorbance values of 20µg/ml 
tranexamic acid after heating 45minutes with ascorbic acid at different time 
intervals (section 3.2.2.2.6) were shown in table (4-31) & figure (4-35).     
Table (4-31): Absorbance values for color stability estimation 
            
Figure (4-35): Color stability estimation curve for 530,390 nm respectively. 
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 4.2.3. Validation of the proposed method                                                     
4.2.3.1. Construction of calibration curve [25]                                                          
The absorbance values at ? max 530 &390nm (Table 4-32) that were obtained 
by a procedure mentioned in section (3.2.2.3.1) were plotted against the final 
tranexamic acid concentrations to obtain the calibration curve (Figure 4-36).                                             
Table (4-32): Absorbance values of standard tranexamic acid solutions 
 ?  1 2 3 4 
Conc.(M)  6.36×10-3 9.54×10-3 12.72×10-3 15.9×10-3 
Conc. (w/v %)     1×10-3 1.5×10-3   2×10-3 2.5×10-3  
Conc. (µg/ml)  10 15 20 25 
Absorbance 
sample1 
390 0.130 0.211 0.285 0.367 
530 0.041 0.070 0.091 0.118 
Absorbance  
sample 2 
390 0.113 0.200 0.267 0.336 
530 0.034 0.062 0.085 0.107 
Absorbance 
sample 3 
390 0.139 0.230 0.284 0.353 
530 0.043 0.066 0.091 0.106 
Absorbance 
sample 4 
390 0.121 0.235 0.295 0.372 
530 0.045 0.071 0.088 0.114 
Mean 390 0.12575 0.219 0.28275 0.357 
530 0.04075 0.06725 0.08875 0.11125 
 SD 
 
390  0.011236  0.01635  0.011615  0.016145 
530 0.004787 0.004113 0.002872 0.005737 
In order to evaluate the results, statistical analysis was done and the 
regressions(R), slopes (B) & intercepts (A) were summarized in table (4-33).                                                                                                                            
Table (4-33): R, A & B values for the calibration curves                                                                                                                                 
Curve No. ?  R A B 
Curve1 
 
390 0.99981 -0.0265  0.0157 
530 0.9983 -0.0082 0.00504 
Curve2 390 0.9980 -0.0286 0.01472 
530 0.9983 -0.0127 0.00484 
Curve3 390 0.9947 -0.0079 0.01392 
530 0.9949 0.0016 0.00428 
Curve4 390 0.9911 -0.0288 0.01626 
530 0.9967 0.0011 0.00448 
Curve(Average) 390 0.9970 -0.019 0.01515 
530 0.99893 -0.00455 0.00466 
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Figure (4-36): Standard tranexamic acid calibration curves at 390,530nm. 
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 Statistics of average calibration curve [44]                                                                                                                       
Error of the slope and the intercept      
                ? max 390               ? max 530 
X X2 X` (X-X`)2 y y  (y- y )2 y y  (y- y )2 
10 100 17.5 56.25 0.126 0.133 4.556 ×10-5 0.041 0.0421 1.69×10-6 
15 225 17.5 6.25 0.219 0.208 1.156×10-4 0.067 0.0654 3.61×10-6 
20 400 17.5 6.25 0.283 0.284 1.563×10-6 0.089 0.0887 1 ×10-8 
25 625 17.5 56.25 0.357 0.360 7.563×10-6 0.111 0.112 4.9×10-7 
෍   1350  125   1.703×10-4   5.8×10-6 
X =  Concentration (µg/ml). y =  Absorance for concentrationX.                                                                                              
X`= Average concentration. y  =  Calculated absorbance from equation.                                                  
To estimate the random errors in the y-direction (Sy/x).                                 
Sy/xൌඥσሺݕെþሻ ଶȀሺ݊െ ሻʹ  .                                                                                                          
At ? max 390nm=ඥͳǤ͹ͲʹͷൈͳͲିସȀʹ  ൌ 9.23×10-3.                                                
At ? max 530nm=ඥͷǤͺൈͳͲି଺Ȁʹ  ൌ 1.70×10-3.                                                                                                                              
Standard deviation of the slope (Sb).                                                                                           
Sb ൌ
ୗ୷Ȁ୶ 
ඥσሺ௫ି ௫ҧሻమ 
Ǥ                                                                                                        
At ? max 390nm = 
଴Ǥ଴଴ଽଶଷ
ξଵଶହ
ൌ    8.26×10-4.                                                                                    
At ? max 530nm = 
ଵǤ଻଴ൈଵ଴షయ
ξଵଶହ
ൌ1.52×10-4.                                                              
Standars deviation of the intercept (Sa).                                                                                             
Sa  = Sy/x ඥσݔଶ Ȁ݊σሺݔെݔҧሻଶǤ                                                                                          
At ? max 390nm = ͲǤͲͲͻʹ ඥ͵ͳ͵ͷͲȀͶൈͳʹͷ ൌ 0.0152.                                               
At ? max 530nm = 0.0017ඥͳ͵ͷͲȀͶൈͳʹͷ = 2.79×10-3.                                                           
t-value.                                                                                                               
For (n-2)=2 degrees of freedom and 95% confidence level, t-value is 4.30.        
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 The 95% confidence limits for the slope of the line (b ± t(n-2) Sb).                     
At ? max 390nm = .01515±(4.30×8.26×10-4) = 0.01515±3.55×10-3.                      
At ? max 530nm = 0.00466±(4.30×1.52×10-4) = 0.00466±6.54×10-4.                        
The 95% confidence limits for the intercept of the line (a ± t(n-2) Sa).                                          
At ? max 390nm = -0.019±(4.30×0.0152) =  - 0.019±0.065.                                                   
At ? max 530nm = -0.00455±(4.30×2.79×10-3) = - 0.00455±0.012.                          
Limit of detection (LOD).                                                                                                
The value of y at the limit of detection is Y=Yb+3Sb.   (i.e Yb=a, Sb=Sy/x ).         
At ? max 390nm = -0.019+3(9.23×10-3) =  8.69×10-3.                                            
At ? max 530nm = -0.00455+3(1.7×10-3) = 5.5×10-4.                                                 
The limit of detection is X=y-a/b.                                                                                         
At ? max 390nm =( 0.00869+0.019)/0.01515=  1.83µg/ml.                                             
At ? max 530nm =(5.5×10-4+4.55×10-3) /4.66×10-3= 1.09µg/ml.                                               
Limit of quantification (LOQ).                                                                                      
The value of y at the limit of quantification isY=Yb+10Sb.(i.e.Yb=a, Sb=Sy/x )                    
At ? max 390nm = - 0.019+10(9.23×10-3) =  0.0733.                                              
At ? max 530nm = -0.00455+10(1.7×10-3) = 0.01245.                                               
The limit of quantification is X=y-a/b.                                                                 
At ? max 390nm = (0.0733+0.019)/0.01515 =  6.09 µg/ml.                                                                                           
At ? max 530nm = (0.01245+0.00455)/0.00466 = 3.65 µg/ml.                                                                                          
Molar absorbtivity(ߝሻ[26].                                                                                                    
The concentration of molar solution is 157.2×103 µg/ml.                                                                                                 
At ? max 390nm = -0.019+0.01515(157.2×103) = 2.382×103mol-1cm-1.                           
At ? max 530nm = -0.00455+0.00466(157.2×103) = 0.733×103mol-1cm-1.  
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 4.2.3.2. Construction of sample curve                                                               
The absorbance values at ? max 390&530nm (Table 4-34) that were obtained 
by a procedure mentioned in section (3.2.2.3.2) were plotted against the final 
tranexamic acid concentrations to obtain the calibration graph (Figure 4-37).        
Table (4-34): Absorbance values of sample tranexamic acid solutions 
In order to evaluate the results, statistical analysis was done and the 
regressions(R), slopes(B) and intercepts(A) were summarized in table(4-35).                          
          Table (4-35): R, A & B values for the sample curves                                                                                                                             
Curve No. ?  R A B 
Curve1 
 
390 0.9973 -0.0439 0.01608 
530 0.9958 -0.0136 0.00492 
Curve2 390 0.9992 -0.049 0.0172 
530 0.9959 -0.0143 0.00526 
Curve3 390 0.9966 -0.0044 0.01478 
530 0.9953 0.002 0.0045 
Curve4 390 0.9987 -0.0538 0.01746 
530 0.9969 -0.0125 0.0053 
Curve(Average) 390 0.9992 -0.0378 0.01638 
530 0.9981 -0.0096 0.004995 
 ?  1 2 3 4 
Conc.(M)  6.36×10-5 9.54×10-5 12.72×10-5 15.90×10-5 
Conc.(%w/v)  1×10-3 1.5×10-3 2×10-3 2.5×10-3 
Conc. (µg/ml)  10 15 20 25 
Absorbance 
sample1  
390 0.115 0.205 0.268 0.362 
530 0.035 0.063 0.081 0.111 
Absorbance  
sample2 
390 0.120 0.215 0.292 0.381 
530 0.036 0.069 0.089 0.117 
Absorbance 
sample3       
390 0.144 0.222 0.280 0.371 
530 0.048 0.070 0.088 0.117 
Absorbance  
sample4 
390 0.126 0.200 0.296 0.385 
530 0.043 0.064 0.092 0.122 
Mean 390 0.12625 0.2105 0.284 0.37475 
530 0.0405 0.0665 0.0875 0.11675 
 SD 390 0.012659 0.009883 0.012649 0.01034 
530 0.006137 0.003512 0.004655 0.0045 
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Figure (4-37): Tranexamic acid sample curves at 390,530 nm. 
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 4.2.3.3. Repeatability and reproducibility of the method [26]                                               
One concentration of tranexamic acid was used (20µg/ml) to evaluate the 
repeatability & (25µg/ml) reproducibility (section 3.2.2.3.3) of the 
developed method. The recovery% was calculated in tables below as the 
following:A /Aaverage×100.Where, A is the absorbance value for each sample.                         
Table (4-36): Standard tranexamic acid solutions absorption values on the same day                                                           
 ?  Sample(1) Sample(2) Sample(3) Mean SD 
Abs. 
 
390 0.285 0.284 0.282 0.2836 0.001528 
530 0.088 0.091 0.091 0.090 0.001732 
% 
 
390 100.49% 100.14% 99.44% 100.02  0.53 
530 97.78% 101.11% 101.11% 100 1.9  
At390nm, the recovery is100±0.53%.  At530nm, the recovery is100±1.9%.                                        
Table (4-37): Tranexamic acid capsules solutions absorption values on the same day                                                           
 ?  Sample(1) Sample(2) Sample(3) Mean SD 
Abs. 
 
390 0.292 0.280 0.296 0.28933 0.008327 
530 0.089 0.088 0.092 0.08967 0.002082 
% 
 
390 100.92% 96.78% 102.31% 100 2.876705 
530 99.25% 98.14% 102.60% 99.99 2.32186 
At 390nm, the recovery is100±2.9%. At 530nm, the recovery is99.99±2.3%.                                                                     
Table (4-38): Standard tranexamic acid solutions absorption values in different days                                                          
 ?  Day(1) Day(2) Day(3) Mean SD 
Abs. 
 
390 0.367 0.353 0.357 0.359  0.0072  
530 0.109 0.107 0.106 0.1073 0.0026  
% 
 
390 102.22% 98.33%  99.44%  99.99 2.0  
530  101.58% 99.72%  98.79% 100.03   1.42 
At 390nm, the recovery is99.99±2.0%. At 530nm, the recovery is100±1.42%                                                                                  
Table (4-39): Tranexamic acid capsules solutions absorption values in different days                           
 ?  Day(1) Day(2) Day(3) Mean SD 
Abs. 
 
390 0.381 0.371 0.385 0.379 0.007211 
530 0.117 0.117 0.122 0.11867 0.002887 
% 
 
390 100.53% 97.89% 101.58% 100 1.901236 
530 98.59% 98.59% 102.81% 99.99 2.436418 
At 390nm, the recovery is100±1.9%. At 530nm, the recovery is 99.99±2.4% 
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 4.2.3.4. Added recovery (%) by the ascorbic acid method                                                 
To determine the added recovery (%) by the proposed method 10µg/ml of 
standard tranexamic acid, 10µg/ml tranexamic acid capsules and a mixture 
of both were used (section 3.2.2.3.4). 
The recovery % were calculated in table (4-40) according to the following 
formula: Recovery(%) =(Astd(1)/Astd)×100. Where Astd(1)= Amix-Asample .                                                                     
     Table (4-40): Added recovery (%) using the proposed method 
Sample 
No. 
?  Abs. of 
mixture 
Abs.of 
sample 
Abs. of 
standard(1) 
Abs.of  
standard 
Recovery 
(%) 
1 390 0.285 0.114 0.171 0.123 139.02% 
530 0.092 0.035 0.057 0.037 154.05% 
2 390 0.283 0.120 0.163 0.129 126.36% 
530 0.091 0.04 0.051 0.042 121.43% 
3 390 0.280 0.115 0.165 0.122 134.24% 
530 0.093 0.037 0.056 0.039 143.59% 
                                                                                                                             
At ? max 390nm, the added recovery percent is 133.21±6.39%.                                                                  
At ? max 530nm, the added recovery percent is 139.69±16.7%. 
Using first equation of standard curve(Y=A+BX).                                                      
Y= -0.0265 + 0.0157 X. (at ? max390).                                                                        
Y= -0.0082 + 0.00504 X. (at ? max530).   
Sample 
No. 
?  Abs. of 
mixture 
Conc.of mix. 
(calculated) 
Conc. of mix. 
(theoretical) 
Recovery 
(%) 
1 390 0.285 19.84 20 99.2% 
530 0.092 19.88 20 99.4% 
2 390 0.283 19.71 20 98.55% 
530 0.091 19.68 20 98.41% 
3 390 0.280  19.52 20 97.6% 
530 0.093 20.07 20 100.40% 
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 Using second equation of standard curve(Y=A+BX).                                               
Y= -0.019 + 0.01515X (? max390).                                                                               
Y= 0.0011 + 0.00448X (at ? max530).                                                                           
Sample 
No. 
?  Abs. of 
mixture 
Conc.of mix. 
(calculated) 
Conc.of mix. 
(theoretical) 
Recovery 
(%) 
1 390 0.285 20.06 20 100.33% 
530 0.092 20.29 20 101.45% 
2 390 0.283 19.93 20 99.66% 
530 0.091 20.07 20 100.33% 
3 390 0.280 19.73 20 98.67% 
530 0.093 20.51 20 102.56% 
                                                                                                                                   
At 390, the added recovery is 99.00±0.95 %.                                                                        
At 530, the added recovery is100.43±1.46 %.                                                                                                                            
4.2.3.5. Standard addition method [25]                                                  
Standard addition method samples were prepared by adding aliquot volumes 
(0, 0.1, 0.2, &0.3ml) of standard tranexamic acid to a fixed tranexamic acid 
sample solutions containing10µg/ml (section 3.2.2.3.5). The absorbance 
values were recorded in table (4-41).  A graph was plotted to evaluate the 
possible interference that may occur (Figure 4-38).                                                                                                                          
Table (4-41): Standard addition method results 
Sample 
No. 
Capsule conc. 
(µg/ml) 
Standard conc. 
(µg/ml) 
?  Absorbance 
1 10 
 
0 390 0.125 
530 0.040 
2 10 
 
5 390 0.208 
530 0.063 
3 10 
 
10 390 0.272 
530 0.081 
4 10 15 390 0.340 
530 0.101 
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Figure (4-38): Standard addition method curve.                                                                 
R= 0.9983, A=0.1299, B=0.01418.  (at 390nm).                              
R=0.9988, A= 0.0411, B=0.00402.  (at 530nm). 
Concentration of tranexamic acid in the sample.                                               
The regression equation is y=0.1299+0.01418 x. (at 390nm).                                                         
.                                          y=0.0411+0.00402 x. (at 530nm).                               
The concentration was calculated from the extraplotted x-value when y=0. 
XE =(Y-A)/B  = -0.1299/0.01418= -9.16 µg/ml.   (at 390nm).                                                           
.                      = -0.0411/0.00402= -10.22 µg/ml. (at 530nm).                      
Recovery %.                                                                                                       
The recovery% =(Xaxis contribution/ sample stated amount) ×100.                               
(9.16/10) ×100= 91.6%.       (at 390nm).                                                                                                                                                 
(10.22/10) ×100= 102.2%.   (at 530nm).                                                                          
Confidence limit [44].                                                                                                                                                                    
Sy/xൌඥσሺݕെþሻ ଶȀሺ݊െ ሻʹǤ                                                                                               
Sy/x ൌඥͺ Ǥʹ͹ൈͳͲିହȀʹ  ൌ 6.43×10-3.   (at 390nm).                                                           
Sy/x ൌඥͶǤ͹ൈͳͲି଺Ȁʹ  ൌ 1.53×10-3.     (at 530nm).                                                         
The standard deviation of extra plotted x-value SXE.                                                  
SXE = 
ୗ୷Ȁ୶  
ୠ
  ටଵ௡൅
 ଶ
ୠଶσሺ௫ି ௫ҧሻమ 
Ǥ                                                            
SXE= 
଺Ǥସଷൈଵ଴ି ଷ
଴Ǥ଴ଵସଵ଼
  ටଵସ൅
ሺ଴Ǥଶଷ଺ଶହሻଶ
ሺ ଴Ǥ଴ଵସଵ଼ሻ మǤଵଶହ 
 =0.7128.  (at 390nm).                               
SXE= 
ଵǤହଷൈଵ଴ି ଷ
଴Ǥ଴଴ସ଴ଶ
  ටଵସ൅
ሺ଴Ǥ଴଻ଵଶହሻଶ
ሺ ଴Ǥ଴଴ସ଴ଶሻ మǤଵଶହ 
 = 0.6326. (at 530nm).                                                                          
-Ϭ.Ϯ
-Ϭ.ϭ
Ϭ
Ϭ.ϭ
Ϭ.Ϯ
Ϭ.ϯ
Ϭ.ϰ
-ϮϬ Ϭ ϮϬAbsorance Standard concentration? . ͻ͵Ͳnm -Ϭ.ϬϱϬϬ.ϬϱϬ.ϭϬ.ϭϱ-ϮϬ -ϭϬ Ϭ ϭϬ ϮϬAbsorance Standard concentration? .ͷ͵ͲnmPlease purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 t-value for (n-2)=2 degrees of freedom and 95%confidence level is 4.3.                                                                                                  
The 95% confidence limit for this concentration (XE ± t(n-2)SXE).                                                 
9.16 ± (4.3×0.7128) = 9.16 ± 3.07µg/ml.         (at 390nm).                                                                                                           
10.22 ± (4.3×0.6326) = 10.22 ± 2.72µg/ml.     (at 530nm).                                
Concentration of tranexamic acid in the sample using average calibration 
curve equation.                                                                                                   
Abs.= -0.0265 +0.0157 C.         (at 390nm).                                                  
The concentration is 0.125+0.0265/0.0157= 9.65µg/ml.                               
Abs.=-0.0082+0.00504C.          (at 530nm).                                                             
The concentration is 0.04+0.0082/0.00504 = 9.56µg/ml.                                
Abs.= -0.0079 +0.01392 C.        (at 390nm).                                                  
The concentration is 0.125+0.0079/0.01392 =9.55 µg/ml.                               
Abs.= 0.0016+0.00428C.          (at 530nm).                                                             
The concentration is 0.04-0.0016/0.00428 = 9.72µg/ml.                                      
Abs.= -0.019 +0.01515 C.         (at 390nm).                                                  
The concentration is 0.125+0.019/0.01515 =9.50µg/ml.                               
Abs.=-0.00455+0.00466C.        (at 530nm).                                                             
The concentration is 0.04+0.00455/0.00466 =9.56µg/ml.                                    
The recovery percent is 9.56/10×100= 95.6± 0.76%.     (at 390nm).                                                                                   
The recovery percent is 9.61/10×100 = 96.1± 0.92%.    (at 530nm). 
4.2.3.6. Assay of tranexamic acid capsules by the proposed method            
Direct standard/sample comparison method                                       
The direct standard / sample comparison method was used to assay 
tranexamic acid capsules by the developed method. The assay was carried 
out in three concentrations10, 15 &20µg/ml and the procedure was repeated 
three times (section 3.2.2.3.6).  
The following formula was adopted to calculate the content of tranexamic 
acid in capsules (Table 4-42, 4-43 & 4-44) as percent (%w/w) considering 
equal sample and standard concentration. Content% = Asample/Astandard ×100. 
Where, Asample: absorbance of the sample. Astandard: absorbance of the 
standard.                                                                                                                                                         
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 Table (4-42): Content percent statistics for capsule (15µg/ml)   
 Conc.(µg/ml) ?  Abs. 1 Abs. 2 Abs. 3 Abs. mean SD 
Sample 15 390 0.200 0.215 0.22 0.2123  
530 0.063 0.070 0.069 0.0673  
Standard 15 390 0.200 0.211 0.230 0.2137  
530 0.062 0.070 0.071 0.0677  
Content% 
         
 390 100% 101.9% 96.52% 99.47% 2.728 
530 101.61% 100% 97.18% 99.6% 2.242 
Table (4-43): Content percent statistics for capsule (20µg/ml)  
 Conc.(µg/ml) ?  Abs. 1 Abs. 2 Abs. 3 Abs. mean SD 
Sample 20 390 0.268 0.280 0.296 0.2813  
530 0.088 0.092 0.089 0.0897  
Standard 20 390 0.267 0.284 0.295 0.282  
530 0.088 0.091 0.085 0.088  
Content%  390 100.37% 98.59% 100.34% 99.77% 1.019 
530 100% 101.1% 104.71% 101.94% 2.464 
Table (4-44): Content percent statistics for capsule (10µg/ml)  
 Conc.(µg/ml) ?  Abs. 1 Abs. 2 Abs. 3 Abs. mean SD 
sample 10 390 0.115 0.120 0.126 0.1203  
530 0.035 0.043 0.048 0.042  
standard 10 390 0.113 0.121 0.130 0.1213  
530 0.034 0.043 0.045 0.0407  
Content%            390 101.77% 99.17% 96.92% 99.29% 2.427 
530 102.94% 100% 106.67% 103.2% 3.343 
Table (4-45): Mean content percent of the three concentrations 
?  Mean content percent Mean SD 
  µg/ml 20µg/ml  µg/ml   
 99.47 99.77 99.29 99.51 0.2425 
 99.6 101.94 103.2 101.58 1.8268 
Capsules content percent is99.51±0.24%(at390nm)&101.58±1.8%(at530nm)                  
Slope method                                                                                                                       
The following formula was adopted to calculate the content of tranexamic 
acid in capsules (Table 4-46) as percent (% w/w).  
Content %=Slopesample curve/slopestandard curve×100.                                        
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 Table (4-46): Content percent using slope method 
Slope  ?  Curve 1 Curve 2 Curve 3    Mean  S.D 
Sample 390 0.01608 0.01478 0.0172 0.01602  
530 0.00492  0.0045 0.00526 0.00489  
Standard 390 0.01626 0.01472 0.0157 0.01556  
530 0.00484 0.00448 0.00504 0.00479  
Content%             390 98.89% 100.41% 109.55% 102.95% 5.8 
530 101.65% 100.44% 104.37% 102.15 2.01 
Capsules content percent is 102.95 ±5.8%(390nm)& 102.15 ±2.0%(530nm)                                                                               
4.2.4. Kinetics of tranexamic acid–ascorbic acid complex reaction 
The absorbance values of 10, 15, 20&25µg/ml of tranexamic acid after 
heating at different time intervals with ascorbic acid in presence of DMSO 
(section 3.2.2.4) at 390nm & 530nm were recorded in table 4-47 and figure 
4-39.                                                                                                               
Table (4-47): TA-AA complex absorbance values at different time intervals 
Time 
(min.) 
?  
 
Concentration (µg/ml). 
10 15 20 25 
Absorbance. 
10 390 0.014 0.024 0.036 0.029 
530 0.003 0.005 0.006 0.005 
15 390 0.037 0.050 0.081 0.083 
530 0.010 0.012 0.021 0.020 
20 390 0.055 0.100 0.145 0.171 
530 0.016 0.028 0.039 0.048 
25 390 0.061 0.110 0.177 0.182 
530 0.015 0.029 0.052 0.053 
30 390 0.058 0.137 0.199 0.253 
530 0.027 0.043 0.063 0.079 
40 390 0.096 0.178 0.223 0.282 
530 0.022 0.048 0.079 0.089 
45 390 0.113 0.200 0.267 0.336 
530 0.034 0.062 0.085 0.107 
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 Figure (4-39): Absorbance
Reaction order [45] 
The reaction order with respect to 
studying the reaction at different concentrations of 
a constant concentration of ascorbic acid. For each run a plot of A
versus time and Log A
4-41, 4-42, 4-43).   
Table (4-48): Reaction order estimation using 
Time 
(min.) 
?  Abs.
10 
 
390 0.014
530 0.003
15 
 
390 0.037
530 0.010
20 
 
390 0.055
530 0.016
25 
 
390 0.061
530 0.015
30 
 
390 0.085
530 0.027
40 
 
390 0.096
530 0.022
 
Ϭ
Ϭ.Ϭϱ
Ϭ.ϭ
Ϭ.ϭϱ
Ϭ.Ϯ
Ϭ.Ϯϱ
Ϭ.ϯ
Ϭ.ϯϱ
Ϭ.ϰ
Ϭ ϭϬ ϮϬ
Absorb
ance
Time(minutes)     
? ͵ͻͲnm
-time curve of different tranexamic acid concentrations.
tranexamic acid was ascertained by 
tranexamic acid
8 /A8 - At versus time were constructed
10µg/ml tranexamic acid
 A8 /A8 - At Log A8 /A8 - At 
 1.14 0.057 
 1.097 0.040 
 1.49 0.173 
 1.417 0.151 
 1.95 0.290 
 1.889 0.276 
 2.17 0.336 
 1.789 0.253 
 4.04 0.606 
 4.857 0.686 
 6.65 0.823 
 2.833 0.452 
ϯϬ ϰϬ ϱϬ
Ϭ
Ϭ.ϬϮ
Ϭ.Ϭϰ
Ϭ.Ϭϲ
Ϭ.Ϭϴ
Ϭ.ϭ
Ϭ.ϭϮ
Ϭ.ϭϰ
Ϭ ϭϬ ϮϬ
Absorb
ance
Time (minutes)
? ͷ͵Ͳnm
 
          
 keeping 
8 /A8 - At 
 (Figure 4-40, 
 
1/(A8 /A8 - At) 
0.877 
0.912 
0.671 
0.706 
0.513 
0.529 
0.461 
0.559 
0.248 
0.206 
0.150 
0.353 
ϯϬ ϰϬ ϱϬ
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 Figure (4-40): Reaction order curve of 10µg/ml tranexamic acid. 
  Table (4-49): Reaction order estimation using 15µg/ml tranexamic acid 
Time 
(min.) 
?  Abs. A8 /A8 - At Log A8 /A8 - At 1/(A8 /A8 - At) 
10 
 
390 0.024 1.136 0.055 0.880 
530 0.005 1.088 0.037 0.919 
15 
 
390 0.050 1.333 0.125 0.750 
530 0.012 1.24 0.093 0.806 
20 
 
390 0.100 2 0.301 0.5 
530 0.028 1.824 0.261 0.548 
25 
 
390 0.110 2.222 0.347 0.450 
530 0.029 1.879 0.274 0.532 
30 
 
390 0.137 3.175 0.502 0. 315 
530 0.043 3.263 0.514 0.306 
40 
 
390 0.178 9.091 0.959 0.110 
530 0.048 4.429 0.646 0.226 
 
Ϭ
ϭ
Ϯ
ϯ
ϰ
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ϳ
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Figure (4-41): Reaction order curve of 15µg/ml tranexamic acid.                                                     
Table (4-50): Reaction order estimation using 20µg/ml tranexamic acid 
Time 
(min.) 
?  Abs. A8 /A8 - At Log(A8 /A8 - At) 1/(A8 /A8 - At) 
10 
 
390 0.036 1.156 0.063 0.865 
530 0.006 1.076 0.0318 0.929 
15 
 
390 0.081 1.435 0.157 0.697 
530 0.021 1.328 0.123 0.753 
20 
 
390 0.145 2.189 0.340 0.457 
530 0.039 1.848 0.267 0.541 
25 
 
390 0.177 2.967 0.472 0.337 
530 0.052 2.576 0.411 0.388 
30 
 
390 0.199 3.926 0.594 0.255 
530 0.063 3.864 0.587 0.259 
40 
 
390 0.223 6.068 0.783 0.165 
530 0.079 14.167 1.151 0.071 
 
Ϭ
Ϯ
ϰ
ϲ
ϴ
ϭϬ
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Figure (4-42): Reaction order curve of 20µg/ml tranexamic acid.                                                          
Table (4-51): Reaction order estimation using 25µg/ml tranexamic acid 
Time(min.) ?  Abs. A8 /A8 - At Log(A8 /A8 - At) 1/(A8 /A8 - At) 
10 
 
390 0.029 1.094 0.039 0.914 
530 0.005 1.049 0.021 0.953 
15 
 
390 0.083 1.328 0.123 0.753 
530 0.020 1.230 0.090 0.813 
20 
 
390 0.171 2.036 0.309 0.491 
530 0.048 1.814 0.259 0.551 
25 
 
390 0.182 2.182 0.339 0.458 
530 0.053 1.981 0.297 0.505 
30 
 
390 0.253 4.048 0.607 0.247 
530 0.079 3.821 0.582 0.262 
40 
 
390 0.282 6.222 0.794 0.161 
530 0.089 5.944 0.774 0.168 
 
Ϭ
ϭ
Ϯ
ϯ
ϰ
ϱ
ϲ
ϳ
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Figure (4-43): Reaction order curve of 25µg/ml tranexamic acid. 
 Rate constant method [45]                                                                                 
The first order rate constants (k) corresponding to different concentrations of 
tranexamic acid were evaluated from slopes of the plots of  log (A8 /A8 -At) 
versus time which are summarized in table below.                                                                                                  
Table (4-52): Rate constants of different tranexamic acid concentrations 
Concentration(M) ?  Rate constant(s-1) Intercept Correlation coefficient  
 6.36×10-5 
  
390 0.0260 -0.2251 0.986 
530 0.0168 -0.083 0.790 
9.54×10-5  
 
390 0.0294 -0.3047 0.975 
530 0.0214 -0.1963 0.979 
12.72×10-5 
 
390 0.0249 -0.1791 0.993 
530 0.0368 -0.4292 0.977 
15.90×10-5    
 
390 0.0262 -0.2423 0.985 
530 0.0264 -0.2781 0.983 
Ϭ
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Ϯ
ϯ
ϰ
ϱ
ϲ
ϳ
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 The calibration graph that was constructed by plotting rate constants (k) 
against initial tranexamic acid concentrations does not show linear response 
over the concentration range of 10 -  25µg/ml (6.36×10-5-15.90×10-5M).    
Fixed time method [45]                                                                                            
At preselected fixed time, the absorbance values of different tranexamic acid 
concentrations were measured at 390&530 against blank (Table 4-47). The 
regressions of absorbance versus initial tranexamic acid concentration at 
fixed time starting from 10 to 45 minutes were summarized in table below 
over the concentration range10-25µg/ml.                                                                 
          Table (4-53): Fixed time method results                                                                                                                             
Time (min.) ?   A  B R 
10 
  
390   5.8×10-3 1.14×10-3  0.79  
 530 2.3×10-3  1.4×10-4 0.71  
15 
  
 390 3.6×10-3 3.38×10-3   0.95 
 530 2.1×10-3  7.8×10-4  0.90 
20 
  
390  -0.0198 7.86×10-3   0.993 
 530 -4.7×10-3  2.14×10-3  0.997 
25 
  
 390 -0.018  8.6×10-3  0.95 
 530 -0.0107 2.74×10-3    0.95 
30 
  
390 -0.0647 0.01294 0.996 
530 -8.6×10-3 3.52×10-3 0.998 
40 
  
390 -0.0163 0.01206 0.992 
530 -0.0217 4.64×10-3 0.98 
45 
  
390 -0.0286 0.01472 0.998 
530 -0.0127 4.84×10-3 0.998 
 
At a fixed time 45minutes, the regression equation and the other analytical 
parameters have been calculated (section 4.2.3.1).                                                                                    
Fixed absorption time method [45]    
In a fixed absorption time method (section 3.2.2.4), the absorbance value 
0.067 at 390nm was fixed and the time at which each concentration of 
tranexamic acid can take to attain this value was determined (Table 4-54). 
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           Table (4-54): Results for fixed absorption time method    
Concentration (µg/ml) 96 57.6 38.4 
Calculated heating time 
(minutes) to attain  
absorbance equal to 0.067 
 
19 
 
24 
 
31 
 
Absorbance obtained 0.067 0.072 0.083 
                                                                                                                                                
4.2.5. Comparing TA-AA spectrophotometric method with official 
titrimetric method [44]   
 Assay of tranexamic acid capsules usingofficial titrimetric method[7].                                                                                                                      
The content percent of TREXAMINE® capsules according to titrimetric 
method (section 3.2.2.5.1) is100.61 ±1.6%. This percent is mean of three 
independent analyses of one concentration (500mg) of tranexamic acid 
500mg (section 4.1.5.1).  
Assay of tranexamic acid capsule using TA-DCQ spectrophotometric 
method  
The content percent of TREXAMINE® capsules according to the proposed 
method at ? max.390 is 99.51±0.24%. This value is mean of three independent 
analyses of three concentrations (10, 15&20µg/ml) tranexamic acid (section 
4.2.3.6).                                                                       
t-test                                                                                                                             
To evaluate the accuracy of the proposed method comparing with titrimetric 
method, t-test was made.                                                                           
Calculated t-value                                                                                            
(X`1-X`2)/ට ܵܦଵଶ ଵ݊ൗ ൅ ܵܦଶ
ଶ
ଶ݊
ൗ = (99.51-100.61)/ ටͲǤʹͶଶൗ͵ ൅ͳǤ͸ଶൗ͵ = -1.18.   
Tabulated t-value                                                                                             
The number of degrees of freedom=ሺௌ஽భ
మ
௡భ
൅ௌ஽మ
మ
௡భ
ሻ ଶ ሺ ௌ஽భ
ర
௡భమሺ௡భି ଵሻ
൅ ௌ஽మ
ర
 ௡మమሺ௡మି ଵሻ
ሻൗ                                         
ሺ଴Ǥଶସ 
మ
ଷ
൅ଵǤ଺ 
మ
ଷ
ሻ ଶ ሺ଴Ǥଶସ 
ర
 ଷ  మሺଷି ଵሻ
൅ ଵǤ଺
ర
 ଷమሺଷି ଵሻ
ሻൗ =2.09 ؆ 2.                                                 
At 95%confidence level&2degrees of freedom, the tabulated t-value is 4.30.  
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 F-test                                                                                                                                
To evaluate the precision of the proposed method comparing with titrimetric 
method F-test were made.                                                                        
Calculated F-value                                                                                   
ܵܦଵଶ ܵܦଶଶΤ  =ͳǤ͸ଶͲǤʹͶଶΤ = 44.4.                                                                       
Tabulated F-value                                                                                                  
The numbers of degrees of freedom are n1-1 and n2-1 = 2 & 2 respectively. 
At95% confidence level&F2,2degrees of freedom,the tabulated F-value is19.                                                                                          
Relative standard deviation of the proposed method (RSD)                              
RSD = 0.24/99.51×100 = 0.241%.                                                                             
Relative standard deviation of the titrimetric method (RSD)                               
RSD = 1.6/100.61×100 = 1.59%.                                                                                             
4.2.6. Stoichiometry of the reaction using molar ratio method[31]         
(Fixed ascorbic acid concentration against different TA concentrations).             
Different volumes of 6×10-3 molar solution of standard tranexamic acid with 
0.5ml of 12×10-3 molar solution of ascorbic acid (section 3.2.2.6) showed 
absorbance values as in table 4-55 and figure 4-44. The molar ratio of 
tranexamic acid-ascorbic acid complex was found1:2 respectively.                                                                                            
Table (4-55): Molar ratio method (fixed ascorbic acid concentration) result. 
Conc. of TA (M) Vol.of TA (ml) Molar ratio TA/AA Abs.at 390 
0.6×10-4 0.1 0.1 0.023 
1.2×10-4  0.2 0.2 0.043 
1.8×10-4  0.3 0.3 0.061 
2.4×10-4  0.4 0.4 0.072 
3×10-4   0.5 0.5 0.075 
3.6×10-4  0.6 0.6 0.102 
4.2×10-4  0.7 0.7 0.107 
4.8×10-4 0.8 0.8 0.105 
5.4×10-4 0.9 0.9 0.104 
60×10-4 1 1 0.107 
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Figure (4-44): Molar ratio curve of TA/AA.                                                          
 4.2.7. Confirmation tests for oxidation of ascorbic acid by heating 
A- Silver nitrate reduction test 
The color developed in both heated and non heated solutions of ascorbic 
acid after addition of silver nitrate (section 3.2.2.7A) were observed and 
recorded in table below. 
                Table (4-56): Results of silver nitrate reduction test 
  Stated color for 
identification test[43] 
Heated solution 
(solution A) 
Non heated solution 
(solution B) 
Color Black precipitate Turbid white Turbid black 
 
B- UV spectrum of ascorbic acid. 
The maximum wavelengths for both heated and non heated aqueous 
solutions of ascorbic acid (section 3.2.2.7B) were recorded in table below. 
               Table (4-57): Results of UV spectrum of ascorbic acid 
  Stated ? max for 
identification test[43] 
Heated solution 
(solution A) 
Non heated solution 
(solution B) 
? max 263nm 292nm 262nm 
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 5. DISCUSSION 
Colorimetry is concerned with the determination of the concentration of a 
substance by measurement of the relative absorption of light with respect to 
a known concentration of the substance.  
The chief advantage of UV/visible spectrophotometric methods is that they 
provide a simple means for determining minute quantities of substances. 
Compounds that can be assayed in this region (visible range 370 – 700 nm) 
are basically colored, with high conjugation. Weakly or non UV absorbing 
compounds can be allowed to react with a reagent to give a colored 
compound with higher intensity absorption.  
It is largely desirable that the reaction product absorbs strongly in the visible 
rather than in the ultraviolet because the interfering effect of other 
substances in the ultraviolet is usually more pronounced.                                                                                                            
5.1. Tranexamic acid                                                                                                                                                                                             
Tranexamic acid is a cyclohexane ring containing two functional groups, 
carboxylic acid and primary aliphatic amine[6].Thus, it has no UV/Visible 
absorption (lacking conjugation in its structure). Therefore, a suitable 
chromogen is needed to react with tranexamic acid to form a UV or visible 
absorbing chromophore that can be used for simple and sensitive 
determination of tranexamic acid in bulk and in different pharmaceutical 
formulations.   
2,6-dichloroquinone-4-chlorimide (DCQ) has been used as a chromogenic 
reagent for spectrophotometric determination of thiol containing drugs 
(Captopril[33], ? max 443&D-penicillamine[34], ? max 431), amine containing 
drugs (Pregabalin[35] ,? max 400, Methyl dopa[36], ? max 400 & Na+floxacillin[46])   
and phenolic drugs (Propofol[47],  ? max 635 & Cefadroxil[48] ,? max 620).   
Ascorbic acid is reported to have a selective reaction with ammonia and 
primary aliphatic amines[49]. This coupling reagent has been used for 
colorimetric determination of a number of drug containing primary amine 
Such as Alfuzocin[39](? max 530nm), Lisinopril[40](? max 530nm), Penicillins[50] 
(? max 410nm) and Cephalosporins[50] (? max 406nm).    
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 Based on these reports, two methods for tranexamic acid assay were 
developed. The first is based on coupling  with DCQ in presence of DMSO 
to produce a greenish-brown colored complex having analytically useful 
maximum at ? max 670 and a non-stable rather approximately flat peak around 
412nm(section 4.1.1.1).The coupling reagent blank showed peak at 278nm 
(section4.1.1.2).  
The second method is based on reaction with ascorbic acid in presence of 
DMSO to produce a pink-purple colored complex that absorb at ? max530 & 
? max390nm (section4.2.1.1).The coupling reagent blank showed peaks at 270 
& 304nm (section 4.2.1.2).  
5.2. Proposed reaction mechanisms                                                                
5.2.1. Tranexamic acid-DCQ coupling complex 
The unshared pair of electrons on the nitrogen of tranexamic acid (2) attacks 
the electrophilic nitrogen of DCQ (1) to give intermediate (I). The 
negatively charged oxygen abstracts a proton from the positively charged 
nitrogen to give intermediate (II). One of the two lone pairs of electrons on 
oxygen in (II) resonates with the p  system of the ring and chloride ion 
departs as a leaving group giving the quinone moiety (III). Intermediate III 
loses a proton to give product 3 (scheme 5-1).   
This formed product (3) couples with another molecule of tranexamic acid to 
give chromophores 4 or 5 (scheme 5-1).   
The possibility of formation of chromophore 4 is greater than that of 5 
because the nucleophilic attack is easier at the less steric hindered site of the 
molecule. In addition the mechanism that leads to formation of this 
chrmophore (4) is base catalyzed while in case of other chromophore (5) the 
mechanism is acid catalyzed. It was observed that alkaline media (pH 8.5) 
increases the reaction rate and absorbance intensity more than the neutral 
media (section 4.1.2.4). Thus, chromophore 4 is expected to be the formed 
colored product.     
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Scheme (5-1): Reaction mechanism of tranexamic acid with DCQ 
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 The molar ratio between tranexamic acid and DCQ was found to be 2:1 
respectively (section 4.1.6).  
When a chromophore is exposed to the UV-visible light, electronic 
transitions occur within the molecule from non-bonding (n) and bonding (p ) 
orbitals to the excited anti-bonding (p *) orbitals[25].  
Since n-electrons have higher energy levels for the ground state than p -
electrons, they are relatively more unstable and consequently require lesser 
energy for excitation. Therefore, they absorb UV-visible light at longer 
wavelength than p -electrons[25].  
 UV/visible absorption spectrum of tranexamic acid-DCQ coupling complex 
(Figure4-1) shows two bands with different intensities at 412 and 670nm. 
This could be explained by the presence of both type of electronic transitions 
n՜p * (670nm) and p ՜p * (412nm). 
Since the probability of n transition is low and the molar absorbtivity (? ) 
depends on the number of electrons undergoing transition, the intense bands 
(large ? ) are produced by p ՜p * transition whereas n՜p * transition produce 
relatively weak bands[25]. Accordingly, the absorbance at 412nm is always 
higher than that at 670nm of the resulting chromophore. However, the 
absorbance at 670nm was more stable and useful than that at 412nm.     
 
5.2.2. Tranexamic acid-ascorbic acid coupling complex 
It is suggested that the colored product (3 in scheme 5-2) is produced 
through the same mechanism that generates Ruhemann’s purple from 
reaction of ninhydrin with amines[42](section1.5.6).  
Thus, dehydro ascorbic acid (DHA), 1a, accepts an electron pair from the 
nucleophilic amino group of tranexamic acid (2) to give hemiaminal (II) 
which loses a molecule of water to yield intermediate IV. Deprotonation    of 
IV results in formation of imine (VI). On hydrolysis, imine gives primary 
amine (VII) which, in turn, couples with another molecule of DHA to give 
colored product (3).  
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Scheme (5- 2): Reaction mechanism of tranexamic acid with ascorbic acid 
The proposed mechanism explains why two moles of ascorbic acid are 
required to couple with one mole of tranexamic acid (section 4.2.6) to yield 
the colored coupling complex (3). 
UV/visible absorption spectrum of tranexamic acid-ascorbic acid coupling 
complex (Figure 4-23) shows two bands with different intensities at 390 and 
530nm. This could be explained by the presence of both type of electronic 
transitions n՜p * (530nm) and p ՜p * (390nm). 
5.2.3. Heating induced-oxidation of ascorbic acid                                                           
In coupling reaction of tranexamic acid with ascorbic acid, heating was 
found necessary for the development of purple color. 
The proposed mechanism (section5.2.2) requires oxidation of ascorbic acid 
to dehydro ascorbic acid to produce suitable carbonyl group that can react 
with amino group of tranexamic acid to form schiff’s base.  
?  
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 Literature revealed that ascorbic acid could be air oxidized at higher 
temperature[40] to give dehydro ascorbic acid. Here, we tried to confirm such 
oxidation by silver nitrate reduction test and UV measurement. 
Silver nitrate reduction test[43]                                                                                       
It was found that the aqueous ascorbic acid solution(B)reduces silver nitrate  
immediately producing a black precipitate while no black precipitate was 
observed when the aqueous ascorbic acid solution was used after heating(A)  
and then cooling (section 4.2.7A). 
UV spectrum of ascorbic acid[43]  
The result obtained in (section4.2.7B) showed that the solution A gives band 
at ? max 292nm while solution B gives band at ? max 262nm. It was worth 
noting that ascorbic acid absorbs at ? max 262nm[43]. 
5.3. Reaction conditions optimization                                                                    
The different experimental parameters affecting the color development were 
studied to determine the optimal condition for the assay procedure.        
5.3.1 Tranexamic acid – DCQ complex. 
Both heating and non-heating methods are approximately equal in R value 
but the heating method was favored because it is faster (only three minutes) 
and it gives higher absorbance intensity (Table 4-1& 4-2). Increasing heating 
time from three to five minutes causes slight increase in absorbance value 
(section 4.1.2.1). Therefore, heating three minutes was adopted as optimum.    
Increasing the absorbance intensity when using DMSO as solvent compared 
with water (section4.1.2.2) may be attributed to the fact that the 
nucleophilicity of anions is strongly enhanced in polar aprotic solvents like 
DMSO and lead to improvements of several types of processes that involve 
nucleophilic substitution or addition [51].  
0.7ml of 0.25% DCQ in methanol was found to be the required volume and 
concentration of coupling reagent for maximum color developments (section 
4.1.2.3).  
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 Although alkaline media increase the reaction rate and absorbance intensity 
but the neutral media was favored because changing absorbance with time 
becomes very slow (section 4.1.2.4) permit satisfactory time for measuring 
and longer time for color stability. The reaction rate can then be accelerated 
by heating. Under these conditions the color intensity remained stable for at 
least two hours (section 4.1.2.5) which was considered to be sufficient time 
for measurement. 
5.3.2. Tranexamic acid – ascorbic acid complex. 
Heating was found necessary for oxidation of ascorbic acid and then 
formation of a colored complex. The maximum color developed after 
45minutes heating in a boiling water bath (section 4.2.2.1) which is selected 
as fixed time of heating.   
For faster and intense color development, DMSO was used as solvent 
(section 4.2.2.2) and the content of aqueous solution of drug does not exceed 
0.5ml in 10ml final volume. The presence of water was found necessary due 
to insolubility of drug in DMSO.   
DMSO was found the suitable solvent for coupling reagent preparation 
(section 4.2.2.3) compared with ethanol and isopropanol. These solvents 
effects may be attributed first to the nature of solvent as polar aprotic 
solvents enhance nucleophilicity of anion compared with polar protic 
solvents [51]. In addition, the slight acidity of alcohol may also play role in 
slowing the reaction.   
The sequence of addition as described in the method (section4.2.2.4) was 
found essential for color stability. For maximum color development, 1ml of 
2% ascorbic acid was chosen as the optimum concentration (section 4.2.2.5). 
Under these conditions, the color remained stable for 24 hours 
(section4.2.2.6).         
5.4. Validation of the proposed methods                                                                                                         
The validity of the proposed method was evaluated regarding linearity, 
sensitivity, precision, accuracy and interference study (selectivity). The 
results were shown below.                                                                                      
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 5.4.1. Tranexamic acid –DCQ complex                                                             
Linearity                                                                                                         
Under the optimum experimental conditions, Beer’s law was found to be 
valid over the concentration range- µg/ml at ? max  nm (Table 4-4). 
The corresponding calibration equation is A= - .100275+3.2985×10-3C.                   
Where, A is the absorbance in one cm cell and C is the concentration of 
tranexamic acid (Table 4-5).                                                                                                   
The standard deviation of the slope (Sa) and the intercept (Sb) as average of 
four replicate analyses at 95% confidence level is 0.0277&1.6697×10-4                     
respectively (section 4.1.3.1). The value of the correlation coefficient 
(R=0.996) obtained from regression equation indicate the good linearity of 
the method (Table 4-5).                                                                                                                              
The detection limit of the studied drug, which represent the minimum level 
at which the analyte can be reliably detected, is 24.01µg/ml and the limit of 
quantification, which represents the lowest concentration that can be 
measured, is 80.04µg/ml. All the results above are average of four 
independent analyses (section 4.1.3.1).                                                                                     
Sensitivity                                                                                                             
The value of the slope of the proposed method (3.2985×10-3) and the molar 
absorbtivity ߝ (518.42 mol-1cm-1) both could indicate suitable sensitivity for 
this non conjugated drug (section 4.1.3.1).                                                                                                                       
Precision                                                                                                                   
The precision of the developed method was evaluated by statistical analysis 
of the regression data regarding standard deviation of the residual (Sy/x) 
0.0264, the intercept (Sa) 0.0277and the slope (Sb) 1.6697×10-4 (average of 
four independent analysis) of the calibration curve. The small value of the 
figures points out to the low scattering of the calibration graph and 
satisfactory precision (section 4.1.3.1).  
Another evaluation of the precision was done by testing the repeatability and 
reproducibility of the method. Three replicate analyses were carried out for 
each. The standard deviation of the mean percent recovery is 99.99 ±1.68%    
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 for repeatability. In case of reproducibility the standard deviation is 
100±2.05% which indicates the precision of the proposed method (section 
4.1.3.3). 
The calculated F-value (6.25) is higher than the tabulated one (19) 
suggesting that there is no significant difference between the proposed 
method and titrimetric method with regard to precision (section 4.1.5).                                                  
Accuracy                                                                                                               
The obtained data above regarding repeatability and reproducibility show 
that the method is accurate as well as precise. The mean percent recovery is 
99.99 ±1.68% for repeatability. In case of reproducibility the mean percent 
recovery is 100±2.05% which indicates the accuracy of the method (section 
4.1.3.3).                                                   
To check the accuracy of the proposed method an amount of reference 
tranexamic acid (100µg/ml) was added to tranexamic acid capsules          
(100µg/ml) and subsequently assayed by the proposed method. The mean 
percentage added recovery of the three independent analysis using 
calibration curve equation is101.28 ±1.35% (i.e. less than 2%) indicating 
that the method give accurate results (section 4.1.3.4).                                                           
The mean percentage added recovery which reflects the accuracy of the 
method obtained by the formula (Abs.of mix.-  Abs. of sample / Abs. of 
STD × 100) shows high recovery percent (169.57±5.12%). This may be due 
to the high intercept value in addition the linearity of curve is not duplicated 
of absorbance with the concentration. However, result calculated by linear 
calibration curve equation shows good accuracy (section 4.1.3.4).                            
The calculated t-value (0.493) is less than the tabulated one (3.18) 
suggesting that there is no significant difference between the proposed 
method and titrimetric method with regard to accuracy (section 4.1.5). 
 Selectivity (Interference study)                                                                        
Possible interference from tranexamic acid capsule excipients and other 
structurally related degradation products were investigated under the 
optimum experimental condition by the following method.                             
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 As shown above the result obtained from added recovery method using 
linear calibration curve equation (101.28±1.35%) explains a good recovery 
percent with low standard deviation (section 4.1.3.4).                                                 
When the proposed method was applied to capsules labeled to contain 
250mg tranexamic acid, the mean content percent of three independent 
analyses was found to be 100.12±0.64% using direct standard sample 
comparison method (section4.1.3.6). This shows that the proposed method is 
selective and specific.                                             
The recovery percent obtained by standard addition method when using 
standard addition equation is 63.52% but when using linear calibration curve 
equation (section 4.1.3.5) it gave good recovery percent (101.69±0.16%).  
The standard addition method was found to be suitable only when very low 
concentrations are used like in atomic absorption and atomic emission 
spectroscopy[26] and this may explain the results obtained above.                                                               
5.4.2. Tranexamic acid-ascorbic acid complex                                              
Linearity                                                                                                            
Under the optimum experimental condition, Beer’s law was found to be 
valid over the concentration range10 - 25µg/ml at ? max 390 & 530nm (Table 
4-32). The corresponding calibration equation is A= - 0.019+0.01515C 
(at390nm) and A= - 0.00455+0.00466C (at 530nm). Where, A is the 
absorbance in one cm cell and C is the concentration of tranexamic acid 
(Table 4-33).                                             
The standard deviation of the slope (Sa) is 0.0152 (? max390) & 0.00279 
(? max530) and the standard deviation of the intercept (Sb) is8.26×10-4 
(? max390) & 1.52×10-4 (? max530) as average of four replicate analyses at 95% 
confidence level (section 4.2.3.1).                 
The value of correlation coefficient (R=0.997at ? max390& 0.9989 at ? max530) 
obtained from regression equations indicate good linearity of the developed 
method (Table 4-33).                   
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 The detection limit of the studied drug, which represent the minimum level 
at which the analyte can be reliably detected is1.83µg/ml (? max390) & 
1.09µg/ml (? max530). The limit of quantification, which represents the lowest 
concentration that can be measured, is 6.09µg/ml (? max390) &3.65µg/ml 
(? max530). All the results are average of four independent analyses (section 
4.2.3.1).                                                                                                     
Sensitivity                                                                                                            
The value of the slope (0.01515 at ? max 390 & 0.00466 at ? max 530 nm) of the 
proposed method and the molar absorbtivity (2.382×103mol-1cm-1 at 
? max390& 0.733×103mol-1cm-1 at ? max530) both could indicate suitable 
sensitivity of the non conjugated drug (section 4.2.3.1). 
 Precision                                                                                                            
The precision of the method was evaluated by statistical analysis of the 
regression data regarding standard deviation of the residual Sy/x (9.23×10-3 at 
? max390 &1.70×10-3 at ? max530),the intercept Sa (0.0152 at ? max390&0.00279 
at ? max530) and the slope Sb (8.26×10-4 at ? max390 & 1.52×10-4 at ? max530) of 
the calibration curve. The small value of the figures point out to the low 
scattering of the calibration graph and satisfactory precision. These values 
are average of four independent analyses (section 4.2.3.1).                                                                                       
Another evaluation of the precision was done by testing the repeatability and 
reproducibility of the method. Three replicate analyses were carried out for 
each.  The standard deviation for repeatability is 100±0.53% (at ? max390) 
&100 ± 1.9(at ? max530).  In case of reproducibility the standard deviation is 
99.99±2.0% (at ? max390) & 100 ± 1.42% (at ? max530) which indicate the 
precision of the proposed method (section 4.2.3.3). 
Although the calculated F-value (44.4) is higher than the tabulated one (19), 
it is suggested that this could be due to comparing of small standard 
deviation value. However, the RSD for the proposed method is 0.24% and 
the RSD for the titrimetric method 1.59%.  Both values lie between accepted 
RSD value (less than 2%) for assay (section 4.2.5).                                                                                    
Accuracy                                                                                                            
The obtained data above regarding repeatability and reproducibility show 
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 that the method is accurate as well as precise. For repeatability the mean 
percent recovery is 100±0.53% (at ? max390) &100 ± 1.9(at ? max530). In case 
of reproducibility the mean percent recovery is 99.99±2.0% (at ? max390) & 
100±1.42% (at ? max530) which indicate the accuracy of the method (section 
4.2.3.3).                                                      
To check the accuracy of the proposed method an amount of reference 
tranexamic acid (10µg/ml) was added to tranexamic acid capsule (10µg/ml) 
and subsequently assayed by the proposed method. The mean percentage 
added recovery of the three independent analysis using calibration curve 
equation is 99±0.95% (at ? max390) &100.43±1.46% (at ? max530) indicating 
that the method give accurate result at ? max390nm (section 4.2.3.4). 
The mean percentage added recovery which reflects the accuracy of the 
method obtained by the formula (Abs.of mix.-  Abs. of sample / Abs. of 
STD × 100) show high percent recovery (133.21±6.39% at ? max390nm 
&139.69±16.7 at ? max530nm). This may be due to the high intercept value, 
and in addition the linearity of curve is not duplicated of absorbance with the 
concentration. However, the results calculated by calibration curve equation 
show good accuracy (section 4.2.3.4).    
The calculated t-value (1.18) is less than the tabulated one (4.30) suggesting 
that there is no significant difference between the proposed method and 
titrimetric method with regard to accuracy (section 4.2.5).  
Selectivity (Interference study)                                                                   
Possible interference from tranexamic acid capsule excipients and other 
structurally related degradation products were investigated under the 
optimum experimental condition by the following method.                                  
As shown above the results obtained from added recovery using linear 
calibration curve equation (99±0.95% at ? max390&100.43±1.46 at ? max530) 
explains a good recovery percent with low standard deviation (section 
4.2.3.4).                                                   
When the proposed method was applied to capsules labeled to contain 
250mg tranexamic acid, the mean content percent of three independent 
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 analyses was found 99.51±0.24 % (at ? max390) &101.58±1.8% (at ? max530) 
using direct standard sample compare. This exhibits that the proposed 
method is selective and specific (section 4.2.3.6).                                                                                                              
The recovery percents obtained by standard addition method when using 
standard addition equation are 91.6% (at ? max390) &102.2% (at ? max530) but 
when using linear calibration curve equation, the recovery percents are 
95.6±0.76% (at ? max390) & 96.1±0.92% (at ? max530). The standard addition 
method was found to be suitable only when very low concentrations are used 
like in atomic absorption and atomic emission spectroscopy[26] and this may 
explain the results obtained above (section 4.2.3.5).                   
5.5. Kinetic methods evaluation                                                                                 
The validity of the proposed kinetic methods for tranexamic acid 
determination were evaluated and compared with the non-kinetic (heating) 
one.    
5.5.1. Tranexamic acid-DCQ complex                                                                    
It was found that the reaction resulting in the formation of a colored complex 
from tranexamic acid and DCQ follows first order kinetic in tranexamic 
acid. This is indicated by the n-value (0.89) in the plot of log rate versus log 
C and the straight line of log (A8 /A8 -At) versus time plot (section 4.1.4).  
Calibration graph that was constructed by plotting rate constants (k) against 
initial tranexamic acid concentrations (Table 4-25) does not show linear 
response over the concentration range of 50 -  250µg/ml. Thus, rate constant 
method was found not suitable for estimation of tranexamic acid 
concentration over this range.    
For the fixed time method, the most acceptable value for correlation 
coefficient (0.997) was found at 45 minutes (Table 4-26). Therefore, it was 
utilized as fixed time for assay by this method.   
 For the fixed absorption time method, there is difficulty to find a suitable 
absorbance value that can be fixed to determine the time at which each 
concentration of tranexamic acid can take to attain this value over the range 
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 50-250µg/ml (section 4.1.4). For 0.074 as fixed absorbance value, 100µg/ml 
take too much time to attain this value and 250µg/ml give higher absorbance 
value than fixed one from zero time (Table 4-27).    
Table (5-1) indicates that all the three methods are approximately equal in 
R-value. The initial rate method has the highest sensitivity confirmed by the 
slope value. The lowest standard deviation for slope and intercept (Sb & Sa), 
which indicate the precision, was found in fixed time method (data in table 
5-1 were obtained from section 4.1.4).  
The heating method was favored because it was faster ‘only three minutes’ 
with higher absorbance intensity and accuracy (section 4.1.3.1).    
5.5.2. Tranexamic acid-ascorbic acid complex                                                      
The reaction of tranexamic acid with ascorbic acid follows first order kinetic 
in tranexamic acid. This is indicated by the straight line of log(A8 /A8 - At) 
versus time plot (section 4.2.4).    
The calibration graph of rate constants against tranexamic acid 
concentrations (Table 4-52) over the concentration range of 10-25µg/ml 
does not show linear response. Thus, rate constant method was found not 
suitable for estimation of tranexamic acid concentration over this range.    
 It was evident from table 4-53 that the most acceptable value of correlation 
coefficient was obtained at a fixed time of , 45 minutes. Therefore, the 
fixed time 45minutes was utilized for assay of tranexamic acid by fixed time 
method as the absorbance intensity is higher than in 30 minutes.     
In a fixed absorption time method, it was found over the concentration range 
of 38 -  96µg/ml there is difficulty to establish this method because the 
resulting absorbance usually become higher than expected one 
corresponding to the theoretical calculated heating time (Table 4-54).       
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 5.6. Comparing the proposed methods with other reported methods  
The adopted (BP 2002) formal titration method for assay of tranexamic acid 
injection (section 3.2.1.5) was compared with the proposed methods. t-test 
and F-test indicate that there is no significant difference in accuracy and 
precision between TA-DCQ developed method and titrimetric method 
(section 4.1.5).   
For TA-AA method, t-test indicates that there is no significant difference in 
accuracy between this proposed method and titrimetric method 
(section4.2.5). Although the calculated F-value is higher than the tabulated 
one, it is suggested that this could be due to comparing of small standard 
deviation value. However, the RSD for this proposed method (TA-AA) is 
0.24% and for the titrimetric method is 1.59% (section 4.2.5).  Both values 
lie between accepted RSD values for assay (less than 2%).                                                                                      
Comparing with non-spectrophotometric reported methods applied for assay 
of tranexamic acid in bulk, pharmaceutical formulation and biological fluids        
(HPLC-ELS[9], RP-HPLC[10], LC-MS[11] and TLC-densitometric method[12]), 
although these methods are efficient and stability indicators but at the same 
time their instruments  are complicated and required highly skilled analyst. 
Therefore, they are not easy for routine analysis.                                                                            
The two proposed methods in addition to using simple, relatively non-
expensive instrument and available in all pharmaceutical laboratories, they 
have several advantages compared to the reported spectrophotometric 
methods. These reported methods are described in more details in section 
1.3. 
In addition to accuracy, precision, selectivity and sensitivity (section5.4), 
both developed methods (section 3.2.1.3.6 & section 3.2.2.3.6) are simple 
(does not involve several and complicated steps or pH adjustment and the 
preparation required only for coupling reagent) and economic (very low 
concentration of coupling reagent and DMSO as solvent are only required). 
Other spectrophotometric methods (section 1.3) need more than one reagent 
for derivatization each with different solvent, buffer system having at least 
three chemicals or solvent mixture of two or more.               
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 Ascorbic acid is the safest coupling reagent over all spectrophotometric 
reported methods (described in more details in section 1.3) and DMSO can 
be considered relatively safe solvent compared with methods using glacial 
acetic acid [15].                                                                     
The DCQ method is rapid (only three minutes) and the ascorbic acid method 
forms very stable complex (24 hours).  
Ascorbic acid method has two wavelengths (? max1530, ? max2930) which can 
be used for identification by absorbance ratio and for impurity detection by 
purity index.  Although two of the reported methods have two wavelengths 
(? max1571, ? max2335 for ninhydrin method [24] and ? max1299, ? max2286for 
acetic acid method [15]) but they applied only for combined dosage forms 
containing tranexamic acid. 
DCQ method posses the highest ? max (670nm), and therefore lowest 
possibilities of interference, of all the reported spectrophotometric methods 
(section 1.3) except for the TCNQ method[20]( ? max750 ) and the widest linear 
range (50-250µg/ml).                                                                         
The two proposed methods can be applied for tranexamic acid assay in bulk 
and pharmaceutical formulations.                                                                        
Comparison of linearity and sensitivity of the proposed methods with some 
other spectrophotometric method are presented in table (5-2).       
The limit of detection in ascorbic acid method is low (table 5-2). Thus it 
becomes more valuable if applied in biological assay of tranexamic acid. 
Although SA and BSA [16] methods have low limit of detection (table 5-2) 
but these methods are more tedious to perform.     
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 6. CONCLUSION & RECOMMENDATIONS 
6.1. CONCLUSION  
-In this study two simple, accurate and sensitive sectrophotometric methods 
for determination of tranexamic acid have been developed.   
-Statistical and analytical validation of the results have been carried out and 
revealed the suitability of the proposed methods for assay of this drug in 
pure bulk and capsule formulations. So they can be used as alternative 
methods for the routine analysis of tranexamic acid in quality control 
laboratories. 
-Practical comparison between these two proposed methods and the adopted 
(BP 2002) formal titration method for assay of tranexamic acid injection 
indicates that there is no significant difference between them regarding 
accuracy and precision. 
-The common excipients that can be found in capsule formulations do not 
interfere in the assay of tranexamic acid when these developed methods 
were applied.  
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 6.2. RECOMMENDATONS 
-Both proposed methods can be tested for their ability in determination of 
tranexamic acid in other pharmaceutical formulations (tablet, injection).  
-Validity of the developed methods for assay of tranexamic acid in 
biological fluids can also be examined. However, the presence of free amino 
acids in biological fluids can lead to interference.  
-Supporting of suggested reaction mechanisms between tranexamic acid 
with DCQ and tranexamix acid with ascorbic acid need further structural 
elucidations of the formed colored complexes by nuclear magnetic 
resonance, mass spectrum, infrared spectrophotometry, elemental analysis 
studies and any possible means.   
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